FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1122,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,6538257100.461113,7047358116.98259,1.077864943011429,0.10817641904191203,0.8129420236414158,0.8996655060370997,Upregulated
Feature1121,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,11482994.797372013,16986183.59502754,1.4792468249585013,0.5648627985041577,0.5591997914249005,0.7237768804931469,Upregulated
Feature1120,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,4749385.013236513,1582972.9464599234,0.3333006151424206,-1.5851041147866338,0.4314477433780306,0.6274681631209373,Downregulated
Feature1119,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,1556122.9889774066,1466368.6308276867,0.942321809532098,-0.08570826038816716,0.6817975579614319,0.806087312995497,Downregulated
Feature1118,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,3899487.884781943,1450236.4508653115,0.3719043355731333,-1.4269965282405015,0.42112511481924675,0.616736647023987,Downregulated
Feature1117,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2216007178.61774,1893585369.0753434,0.8545032648569708,-0.22684209077534181,0.018824520837927083,0.376638701722027,Downregulated
Feature1116,NA,C30 H32 O10,552.19968,NA,NA,Feature1116,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2446748.88888308,2165597.9892810266,0.8850920497483515,-0.17610059131927067,0.375569272732505,0.5884538986325448,Downregulated
Feature1115,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,119356109.218745,110361122.14820534,0.9246373970346632,-0.11304038121532396,0.13889237860358714,0.470482482651178,Downregulated
Feature1114,NA,C9 H16 O7,236.0896,NA,NA,Feature1114,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1969381349.60962,1681234618.9647334,0.8536866764265821,-0.2282214317259445,0.010682571707611983,0.3605734563057726,Downregulated
Feature1113,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,1307745914.0513334,1204626410.21651,0.9211471412551662,-0.11849646842552168,0.12597254212712872,0.4627741841989286,Downregulated
Feature1112,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1109073691.840889,921898756.2558067,0.8312330939214678,-0.26667500141767886,0.1662077654922557,0.48555687878974874,Downregulated
Feature1111,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,862656956.9840423,1204281660.2778468,1.396014546139137,0.4813139741646596,0.3345184862196971,0.5724452615273762,Upregulated
Feature1110,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1570203920.7556634,1362065686.3382666,0.8674450931715736,-0.20515565283454357,0.12436497765265941,0.4627741841989286,Downregulated
Feature1109,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,187170740.75790367,229274438.81524432,1.2249480762156075,0.2927205967593624,0.04282785143115356,0.3917457709388165,Upregulated
Feature1108,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,655138375.143151,653359534.5589757,0.9972847864639487,-0.003922552800804064,0.9926849914122913,0.9953463452766674,Downregulated
Feature1107,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1915270.6015918688,995603.3824445964,0.5198238732516988,-0.9439052028415005,0.2714025750832901,0.5329450515616403,Downregulated
Feature1106,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,1466623875.4210567,1214926626.3810267,0.8283832322259382,-0.2716297434406151,0.011154244850366474,0.3605734563057726,Downregulated
Feature1105,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,498107653.74608034,562646266.0515567,1.1295675981288498,0.175770610321167,0.661278102956999,0.7943833313894569,Upregulated
Feature1104,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,348785061.4428037,314703717.333995,0.9022855395015317,-0.1483440303278021,0.17032618738877064,0.48603027309044494,Downregulated
Feature1103,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,1396372496.7359366,1238827414.13824,0.8871754614431586,-0.17270863261570576,0.1906544252273563,0.48745712214463777,Downregulated
Feature1102,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,1175956986.3032234,1176432882.47229,1.0004046884151458,5.837238644582264e-4,0.9891409691928561,0.9944589313928177,Upregulated
Feature1101,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,62899380.68636883,55167261.42825707,0.8770716154318604,-0.18923344718870572,0.08125001966027713,0.4407379248873613,Downregulated
Feature1100,NA,C32 H36 O10,580.23111,NA,NA,Feature1100,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,1650677.4953030932,1518442.8067155466,0.9198906576458378,-0.12046570876883961,0.5053203521223506,0.6871399222855217,Downregulated
Feature1099,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,985898151.67215,880721821.3243986,0.8933192742380486,-0.16275220505301863,0.09682758212171849,0.4438331226509661,Downregulated
Feature1098,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,12229868.5556654,13545721.415141335,1.1075933771067699,0.14742833219795584,0.6902855247686188,0.8103781128808827,Upregulated
Feature1097,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,94224390.09375347,90893115.80769633,0.9646453080487704,-0.05192952181618617,0.02959370791455247,0.39036770986176245,Downregulated
Feature1096,NA,C6 H11 N O7,209.05352,NA,NA,Feature1096,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,847248569.2094843,743360781.002183,0.8773821615252384,-0.18872272035229984,0.03514223081279746,0.3917457709388165,Downregulated
Feature1095,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1149782.9146958534,1145055.6226031792,0.9958885351032333,-0.005943817305642771,0.9937901128977036,0.9955647380993066,Downregulated
Feature1094,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,60104395.49458283,55300271.509933,0.9200703385315169,-0.12018393679207015,0.25861651535330754,0.5190835961116477,Downregulated
Feature1093,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,889981418.462701,776163000.42276,0.8721114669601261,-0.1974155532874607,0.00185736670198792,0.18945140360276785,Downregulated
Feature1092,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,761610698.7613983,719622252.5076886,0.9448688860043652,-0.08181394611961373,0.5084771584491672,0.6871399222855217,Downregulated
Feature1091,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,1246357.9104501293,799793.5682765583,0.6417045710310518,-0.6400188349290389,0.34504143035698476,0.5724452615273762,Downregulated
Feature1090,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,364398169.0735037,460484878.08704966,1.2636860367818261,0.3376380699695999,0.06780915787535047,0.43620489220914954,Upregulated
Feature1089,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,706733376.2618237,633901143.3770063,0.8969452479093966,-0.1569081732661786,0.29450668126027985,0.5514055908137371,Downregulated
Feature1088,NA,C16 H29 N O12,427.16894,NA,NA,Feature1088,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,757542612.7367674,660620406.8694034,0.8720570906008652,-0.19750550847388185,0.025961271771124235,0.39036770986176245,Downregulated
Feature1087,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,699617027.6993957,557831851.3775953,0.797338871542273,-0.32673509038393744,0.030997594326757964,0.3917457709388165,Downregulated
Feature1086,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,2588091.8307179,1720069.6994515802,0.664609222530739,-0.589421781985247,0.17449989198368943,0.4872332821127231,Downregulated
Feature1085,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,390205436.726668,334079573.81890565,0.856163298547074,-0.22404210254221135,0.06142998953463521,0.43620489220914954,Downregulated
Feature1084,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,871489.1342070057,644901.846672547,0.7399998707492351,-0.4344030761315233,0.25112777309230067,0.5104444953071763,Downregulated
Feature1083,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,7868796.341201753,5903461.59649491,0.7502369283067899,-0.4145818175266561,0.6384177887271587,0.780256870266987,Downregulated
Feature1082,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,611207499.517831,633450774.737632,1.0363923466864335,0.05157026698504807,0.8374795647738635,0.9122835647342475,Upregulated
Feature1081,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,840916.5101639964,588079.2587416706,0.6993313267532146,-0.5159519623016947,0.2132038771398876,0.49223024391321163,Downregulated
Feature1080,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,11232020.259024633,10268119.713619193,0.9141827985369799,-0.12944542175472282,0.2687168232826942,0.5289478521459349,Downregulated
Feature1079,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,351906916.80889034,300811718.48396665,0.8548047910275322,-0.22633310082004182,0.0641637715017716,0.43620489220914954,Downregulated
Feature1078,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,248838774.40378168,225464919.560321,0.9060682769417086,-0.14230832596930862,0.17483695068145522,0.4872332821127231,Downregulated
Feature1077,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,806015.0319478944,546868.591253801,0.6784843577075543,-0.5596125398443774,0.1398721947740219,0.470482482651178,Downregulated
Feature1076,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,915103.5951095483,1124903.801683631,1.2292638862914391,0.29779465255176824,0.5746811525562309,0.7335520513857691,Upregulated
Feature1075,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,13261399.910543634,12403780.690543734,0.9353296615903997,-0.09645315521564544,0.45384769749403553,0.6488498713843506,Downregulated
Feature1074,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3984320.0276429765,3822752.451977873,0.9594491470202803,-0.059721752547880785,0.7872159222488262,0.8844795947365299,Downregulated
Feature1073,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,427265985.884425,394003247.5400367,0.9221498096190932,-0.11692694939791372,0.22376683533647915,0.49581507401192965,Downregulated
Feature1072,NA,C9 H17 N O6,235.10555,NA,NA,Feature1072,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,29330128.8923104,18732098.52642587,0.6386640370795281,-0.6468708796785885,0.02878761666146793,0.39036770986176245,Downregulated
Feature1071,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1071,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,205540.28507624267,178716.96367922766,0.8694984713723384,-0.20174460369303335,0.14375955084474049,0.47069768053866784,Downregulated
Feature1070,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,33834370.6496863,47707493.44663623,1.4100304669647685,0.4957263357191819,0.028523057756020504,0.39036770986176245,Upregulated
Feature1069,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4663011.158240453,4626247.892377533,0.9921159815802816,-0.011419308680608826,0.9670950470554883,0.9813025074337496,Downregulated
Feature1068,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,5852811.725057524,5311619.26715822,0.9075329118170148,-0.13997813127845862,0.1387536161585102,0.470482482651178,Downregulated
Feature1067,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,516033.996629573,540988.2388264453,1.048357748442658,0.06813111556971982,0.8615154919183409,0.9285498385517564,Upregulated
Feature1066,NA,C29 H30 O10,538.18407,NA,NA,Feature1066,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,826891.172336623,681731.0431096946,0.8244507450518115,-0.27849478920776644,0.15045085698743565,0.47268226304818617,Downregulated
Feature1065,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,231073657.71035033,197076888.96442333,0.8528747539516521,-0.22959419990843885,0.24813438120111972,0.5073945532162878,Downregulated
Feature1064,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,358324343.457874,313884585.170418,0.8759789584525381,-0.19103187905721974,0.002867327076609461,0.24540365498606226,Downregulated
Feature1063,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,48783661.3679594,60317982.05814007,1.2364381919426057,0.30619012294126974,0.07120740789353572,0.4407379248873613,Upregulated
Feature1062,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,311815639.51351434,332957560.2894243,1.067802631096038,0.09464500896103484,0.7238363938162096,0.8372623029502961,Upregulated
Feature1061,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,292667114.4534863,311170575.46585536,1.0632235741515461,0.08844499800219717,0.7425707309488836,0.8509437710669626,Upregulated
Feature1060,NA,C9 H19 N O7,253.11617,NA,NA,Feature1060,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,334955561.3579857,273159033.1778903,0.8155082783830838,-0.2942285727980229,0.035741121612943766,0.3917457709388165,Downregulated
Feature1059,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,14088339.797127267,12648614.990675367,0.897807347978257,-0.15552219105046605,0.332166068665716,0.5724452615273762,Downregulated
Feature1058,NA,C6 H14 O4,150.08923,NA,NA,Feature1058,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,1411281.5100215534,954689.1680918407,0.676469691774861,-0.5639027970574941,0.13035058669699665,0.4627741841989286,Downregulated
Feature1057,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1057,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,221574.58660528465,192346.27313772,0.8680881507425205,-0.2040865450956739,0.3370429924561873,0.5724452615273762,Downregulated
Feature1056,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1056,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,1227090.2992884133,1115288.79035707,0.9088889309970288,-0.13782409143631152,0.3908424207532856,0.6007194466920363,Downregulated
Feature1055,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,254256064.46030802,209741120.35822365,0.8249208167499438,-0.2776724516074038,0.013377982920647697,0.3605734563057726,Downregulated
Feature1054,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,6267021.12342031,5622953.452509333,0.8972290569591269,-0.15645175171236472,0.18909424371451605,0.48745712214463777,Downregulated
Feature1053,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,264679933.80165267,280779249.03840864,1.060825597942081,0.08518749351424053,0.29386286923923627,0.5514055908137371,Upregulated
Feature1052,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,662233.2779023607,2303010.9022754603,3.4776429683061245,1.7981098261769906,0.37093840987318255,0.585966913959326,Upregulated
Feature1051,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,174237826.44121367,161007537.39622468,0.9240676418248779,-0.1139296339889406,0.11529002121454177,0.4627741841989286,Downregulated
Feature1050,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,627815.4381310956,915619.5635416894,1.4584215486438814,0.5444077829268736,0.26724702461001265,0.5274244238002164,Upregulated
Feature1049,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,237486096.395459,206090030.80103868,0.8677983003175901,-0.20456833441349204,0.06161360280661648,0.43620489220914954,Downregulated
Feature1048,NA,C6 H15 N O7,213.0849,NA,NA,Feature1048,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,31509591.4707794,28627090.526781302,0.9085198884069569,-0.1384099980481943,0.35714162536612915,0.5729208247262728,Downregulated
Feature1047,NA,C10 H20 O7,252.12091,NA,NA,Feature1047,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,35784761.9488956,35462838.700882405,0.9910039013680477,-0.013037357886036754,0.8492340538601177,0.9206189453440118,Downregulated
Feature1046,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,11572521.860935943,7893913.253582257,0.682125585800693,-0.5518907173209389,0.3515297271251817,0.5724452615273762,Downregulated
Feature1045,NA,C12 H18 O9,306.09515,NA,NA,Feature1045,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,234802351.53608933,162698998.199818,0.692918947086486,-0.5292414892423568,0.03659236770251439,0.3917457709388165,Downregulated
Feature1044,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,1185403.2497381796,1262333.2985587567,1.0648977880207167,0.09071496304054194,0.7798971285788212,0.8794417872014446,Upregulated
Feature1043,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,4533947.729984989,3861649.0570983198,0.8517189184955832,-0.23155069941101444,0.039908203465979036,0.3917457709388165,Downregulated
Feature1042,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,643058.9327560713,625253.515865408,0.9723113761683528,-0.040509693693880335,0.813104773332114,0.8996655060370997,Downregulated
Feature1041,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,280318743.14505136,226428112.19872168,0.8077523095969223,-0.3080151243094282,0.2557236475891765,0.5160466413580144,Downregulated
Feature1040,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,1592322.14477327,1307883.13323318,0.821368425683365,-0.28389860530785954,0.3293575496236834,0.5724452615273762,Downregulated
Feature1039,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,596727.3925893747,547503.1552808357,0.9175096737306786,-0.12420472584736689,0.41746199127994105,0.615243020119386,Downregulated
Feature1038,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,7740772.2545687705,7646022.366826254,0.9877596337126967,-0.017768082875248257,0.9026133384635547,0.9518635835741798,Downregulated
Feature1037,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,447152.26130607136,258444.17836114598,0.5779780194027543,-0.7909134670431166,0.056407075033053096,0.43620489220914954,Downregulated
Feature1036,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,9201091.183872893,9744320.046340803,1.0590396129776485,0.08275655380387383,0.9328646357230679,0.9682461806487347,Upregulated
Feature1035,NA,C9 H17 N O6,235.10557,NA,NA,Feature1035,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,6098850.720978786,5990324.341573107,0.9822054376519873,-0.025903285333328443,0.9683344808212853,0.9813025074337496,Downregulated
Feature1034,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,210411.746243793,152550.43631829234,0.7250091263514357,-0.46392893912656585,0.303918784238203,0.5562754908895005,Downregulated
Feature1033,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1033,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,158866.33482445034,107694.1744880491,0.6778917295917525,-0.5608732251457029,0.20338306769493433,0.48745712214463777,Downregulated
Feature1032,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,152608013.61618933,202014963.43161634,1.3237506907054435,0.4046314369859276,0.055490877640951425,0.43364536838278145,Upregulated
Feature1031,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,515320.6622621977,621285.4342845026,1.2056288050960968,0.26978579158457566,0.6690070415579017,0.7993886055675886,Upregulated
Feature1030,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,98749133.55149743,89947273.93341254,0.9108664623017199,-0.13468853185502624,0.40347775118335377,0.6115057027381818,Downregulated
Feature1029,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,769691.5704118457,677965.1938919947,0.880827100041163,-0.1830692385037616,0.30823167289441283,0.559635581528333,Downregulated
Feature1028,NA,C22 H33 N O6,407.23081,NA,NA,Feature1028,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,745051.9945109977,602904.280017282,0.8092110140755855,-0.30541213850563936,0.08543266843768907,0.4407379248873613,Downregulated
Feature1027,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,493496.82695434697,365724.47553035134,0.7410877954118725,-0.4322836286014506,0.4216016116465223,0.616736647023987,Downregulated
Feature1026,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,33698680.623231165,96504533.86925887,2.86374813744876,1.5179046152167908,0.21510781913391058,0.49414252020044086,Upregulated
Feature1025,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,268380728.91146666,237204349.88029066,0.8838352546487775,-0.17815061605250992,0.34856648994827455,0.5724452615273762,Downregulated
Feature1024,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,5617526.8281835765,4927846.151473638,0.8772269901320708,-0.1889778939900104,0.8231325083422721,0.9027904930205565,Downregulated
Feature1023,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,206240706.942507,195319914.834937,0.9470483190759507,-0.07849005999316858,0.5313528047578647,0.7072097828449871,Downregulated
Feature1022,NA,C10 H15 N O8,277.07983,NA,NA,Feature1022,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,202031139.42353368,199009664.29412666,0.9850445078019737,-0.021739182770610307,0.7610575245840414,0.8642778771085976,Downregulated
Feature1021,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1021,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,152987016.72503966,137139123.48112532,0.8964102079825674,-0.15776901707656793,0.13951820209160357,0.470482482651178,Downregulated
Feature1020,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,9363167.70222994,7814220.206196703,0.8345701427878582,-0.260894786582239,0.2997079516365043,0.555822019398608,Downregulated
Feature1019,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1019,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,938828.9636530554,811345.1331431516,0.8642097384662544,-0.21054660666069855,0.0919186046556529,0.4407379248873613,Downregulated
Feature1018,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,10236679.689249713,8760744.915495133,0.8558189941896329,-0.22462239615604263,0.0709966933156484,0.4407379248873613,Downregulated
Feature1017,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,90493438.84311646,95452124.04302274,1.0547960743154305,0.07696410697855452,0.6110474542098081,0.76346909089466,Upregulated
Feature1016,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,131307120.69126967,108027568.07302234,0.8227091379683635,-0.2815456270343875,0.015677021719035667,0.3605734563057726,Downregulated
Feature1015,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,426565.97112840036,360838.68258819403,0.8459153026990477,-0.24141487420539323,0.19032257306716394,0.48745712214463777,Downregulated
Feature1014,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,4031446.4408155633,3324573.4570745532,0.8246602071692141,-0.27812830087749507,0.6442847766384499,0.7840428626771591,Downregulated
Feature1013,NA,C10 H17 N O9,295.09039,NA,NA,Feature1013,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,152623497.95198435,134199364.42551066,0.879283768399346,-0.18559925807996577,0.1387385776112832,0.470482482651178,Downregulated
Feature1012,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,38990406.423358835,32215888.338296402,0.8262516678717184,-0.2753468160397066,0.16663376933874294,0.48555687878974874,Downregulated
Feature1011,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,65852127.71960647,100265461.01978013,1.522584986877009,0.6065227579996157,0.0012990325108313309,0.18568997398870232,Upregulated
Feature1010,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,12368408.921700906,11617426.880954,0.9392822435366543,-0.09036935855638371,0.7899633159414517,0.8854533870992096,Downregulated
Feature1009,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,173146428.488512,150041551.62812135,0.8665587441676648,-0.20663054163959732,0.026590748277805037,0.39036770986176245,Downregulated
Feature1008,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,250050047.80892968,198195145.130885,0.7926219045650075,-0.33529525731822973,0.03215833624536683,0.3917457709388165,Downregulated
Feature1007,NA,C7 H15 N O5,193.09509,NA,NA,Feature1007,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,74256905.40308397,59883422.42827346,0.8064357395882867,-0.3103685173290203,0.5462673973589844,0.7193803049727471,Downregulated
Feature1006,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,114504676.71211733,103700713.196099,0.9056460938867922,-0.14298070724585787,0.019026510001726213,0.376638701722027,Downregulated
Feature1005,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,10880919.760379834,9804181.882254997,0.9010434869627924,-0.15033135853603943,0.08595753293253619,0.4407379248873613,Downregulated
Feature1004,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,178136004.69971535,157451691.1299,0.8838847115456363,-0.17806988921656416,0.1523089037484212,0.47268226304818617,Downregulated
Feature1003,NA,C6 H14 O4,150.08924,NA,NA,Feature1003,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,708250.006785974,458854.73166627565,0.6478711292196809,-0.6262212257985189,0.3357038368366597,0.5724452615273762,Downregulated
Feature1002,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,1741313.3211417133,1795248.1059031633,1.0309736243940792,0.04400742442027585,0.8767352387196843,0.9384420136440267,Upregulated
Feature1001,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,296987.6641519693,289941.557759143,0.9762747506266092,-0.034640875803160213,0.8889928548430545,0.9468117407205606,Downregulated
Feature1000,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,8445075.571883067,7380718.313437587,0.8739671126225159,-0.19434910274626885,0.21886408231507987,0.49414252020044086,Downregulated
Feature0999,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,5254056.35791907,5112321.52325347,0.9730237315684722,-0.039453102832026736,0.9241182194041915,0.9636251321296494,Downregulated
Feature0998,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,78726622.5887635,77389754.59446093,0.9830188575307512,-0.02470900242613558,0.8573733613474255,0.925864207345343,Downregulated
Feature0997,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,31711460.300771434,25536334.733400166,0.8052714851727895,-0.3124528467133261,0.14128312347001548,0.470482482651178,Downregulated
Feature0996,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,46694805.170032136,40054469.42295136,0.8577928374922866,-0.2212988252621089,0.029682222953874182,0.39036770986176245,Downregulated
Feature0995,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,127387665.30638066,117999092.73083267,0.9262992021011808,-0.11044982400910366,0.34094852063033393,0.5724452615273762,Downregulated
Feature0994,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,146150276.122786,88152439.1212944,0.603163000850128,-0.7293801611865748,0.16226075602681392,0.48036033842238846,Downregulated
Feature0993,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,134502873.97895434,103823157.6396928,0.7719028937325012,-0.37350872866632395,0.08830864801360153,0.4407379248873613,Downregulated
Feature0992,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,2076852.9677115735,1238957.851076459,0.5965553991246825,-0.7452719748524239,0.25712794261278177,0.5179489256939697,Downregulated
Feature0991,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,32039114.226745967,42719804.331110165,1.3333640883070372,0.41507077643109,0.41132181711026283,0.611898054554379,Upregulated
Feature0990,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,66396684.1119044,57120988.94174974,0.8602988192223352,-0.21709023724617474,0.24888613664321615,0.5073945532162878,Downregulated
Feature0989,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,17035513.532669567,16216486.158732234,0.9519223548872385,-0.07108419234939688,0.7391877239900071,0.850634488530039,Downregulated
Feature0988,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,660848.308175309,541833.4756211754,0.8199059737585626,-0.2864696229250918,0.2164560691200421,0.49414252020044086,Downregulated
Feature0987,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,53984314.08227933,47062988.1600224,0.8717900553166629,-0.19794734821215734,0.1799811638817105,0.48745712214463777,Downregulated
Feature0986,NA,C18 H31 N O11,437.18971,NA,NA,Feature0986,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,168733792.461085,143976296.73560065,0.8532748220473136,-0.2289176164759819,0.29852182810492756,0.555822019398608,Downregulated
Feature0985,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,64522933.31662513,58518407.838619135,0.9069396698296285,-0.14092150988048632,0.352685639416145,0.5724452615273762,Downregulated
Feature0984,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,381064.74760584335,272902.586953957,0.716158051009839,-0.48165007968118706,0.03655044144304444,0.3917457709388165,Downregulated
Feature0983,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,8555669.060257146,7662435.0545302965,0.8955974103911866,-0.15907773822565302,0.0873216746221074,0.4407379248873613,Downregulated
Feature0982,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,44735009.38749953,39229456.11659903,0.8769296498138449,-0.1894669853253002,0.3683725777426658,0.5854306405485425,Downregulated
Feature0981,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,13448334.972203366,10223513.919844257,0.7602066680355184,-0.39553641525498595,0.4817118464241935,0.668084909379413,Downregulated
Feature0980,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,156584414.65003768,146817237.96230966,0.9376235705861441,-0.09291925727276953,0.10905023811855921,0.45172120667857957,Downregulated
Feature0979,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,723410.039818642,602893.421111516,0.8334048298011743,-0.26291063402375203,0.7149538917442189,0.8278413483354113,Downregulated
Feature0978,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,90644565.05532016,49864833.91913483,0.5501138859092373,-0.8621977751079831,0.4149689671453557,0.615053079441333,Downregulated
Feature0977,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,98003676.95274283,117688335.79423328,1.200856329614881,0.2640635574126748,0.331511126805566,0.5724452615273762,Upregulated
Feature0976,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,90948861.675485,46077300.23090246,0.5066286634274881,-0.9809993924621526,0.33107840649955667,0.5724452615273762,Downregulated
Feature0975,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1248275.6911243498,851844.910095742,0.6824172866239718,-0.551273902201264,0.04903003281847604,0.4199366169643521,Downregulated
Feature0974,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,84640432.20651937,87649713.34974681,1.0355537071914391,0.05040237836716601,0.7050059835553084,0.8222626959969398,Upregulated
Feature0973,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,17598663.51306033,21447060.338179,1.2186755160278333,0.2853140457824168,0.33614474440778347,0.5724452615273762,Upregulated
Feature0972,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature0972,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,1224435.1959400433,1207372.0415432542,0.9860644691908834,-0.020246121365898925,0.9312155954864381,0.9674295353109107,Downregulated
Feature0971,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1839248.9957459266,1561200.7248664666,0.8488251065937407,-0.23646076589363568,0.5008674662755713,0.6852654226052726,Downregulated
Feature0970,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,124832745.70678233,108888879.055384,0.8722781705943677,-0.1971398092656286,0.004535118981629796,0.31802521858678945,Downregulated
Feature0969,NA,C43 H79 N O9,753.57577,NA,NA,Feature0969,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,13191164.897555033,37706512.373719364,2.8584672139689666,1.5152417429511686,0.3362726478492931,0.5724452615273762,Upregulated
Feature0968,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature0968,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,187461.546600187,152457.006575373,0.8132708245522441,-0.29819223560607355,0.11118761394668768,0.4520018219137086,Downregulated
Feature0967,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature0967,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,1667029.1688209933,1158243.6270393,0.6947950574005062,-0.5253406037767965,0.026255096831688467,0.39036770986176245,Downregulated
Feature0966,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,78564889.3624484,36529797.72172863,0.4649633954577775,-1.104810951290785,0.2946165586281187,0.5514055908137371,Downregulated
Feature0965,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,7616664.55378157,6631515.61134235,0.8706587462946485,-0.19982072795634542,0.3273543097181896,0.5712154517944148,Downregulated
Feature0964,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,801062.6917948104,698047.6090542173,0.8714019716611893,-0.1985897173439419,0.24837050076549266,0.5073945532162878,Downregulated
Feature0963,NA,C12 H18 N6,246.15928,NA,NA,Feature0963,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,807642.3275418567,692336.8546995117,0.8572320086376736,-0.22224237431681096,0.41332134430776435,0.6134213602027931,Downregulated
Feature0962,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,825209.2947083809,547149.2753921733,0.663043035143623,-0.5928255826590552,0.32574795915138566,0.5692978351524217,Downregulated
Feature0961,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,115449876.75295067,93570341.67511857,0.8104845523165713,-0.303143406379167,0.022562620212677024,0.39036770986176245,Downregulated
Feature0960,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,112480847.49682367,106904810.70970881,0.9504267889938123,-0.07335259397191411,0.4737512744459121,0.6603092297246129,Downregulated
Feature0959,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,414015.0491428283,352716.9141963573,0.8519422540958791,-0.2311724491227175,0.11688658711236169,0.4627741841989286,Downregulated
Feature0958,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,2410451.3957162867,1728909.5246023345,0.7172555014694971,-0.47944096613905224,0.3455546268039682,0.5724452615273762,Downregulated
Feature0957,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1379261.4674305099,1447029.4667482567,1.0491335406070577,0.06919832530281422,0.8395916632275546,0.9136972319508402,Upregulated
Feature0956,NA,C9 H15 N O7,249.08484,NA,NA,Feature0956,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,71588580.23391743,70082473.46569604,0.9789616337787375,-0.03067577422259759,0.8286434140160255,0.9061773007075834,Downregulated
Feature0955,NA,C23 H35 N O6,421.24649,NA,NA,Feature0955,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,3477254.4886969435,3321975.43359004,0.9553443512369748,-0.06590725254822564,0.7703440974439439,0.8712964489234931,Downregulated
Feature0954,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature0954,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,131540472.73378399,106640489.90792567,0.8107047792335995,-0.3027514468753164,0.014367773224416973,0.3605734563057726,Downregulated
Feature0953,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,83520099.2147255,76433488.963696,0.9151508401251989,-0.12791853906963682,0.09350962295065987,0.4408310796245394,Downregulated
Feature0952,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,113890185.85726634,95542201.853651,0.8388975848488818,-0.2534334020403569,0.05322062136142881,0.43270679106900817,Downregulated
Feature0951,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1697158.237064356,1325626.3395160814,0.7810858826040119,-0.35644690939469575,0.6475813144635089,0.7863487389914036,Downregulated
Feature0950,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,33403959.719414033,7156907.37391317,0.2142532632068063,-2.2226109172640554,0.22356378982990746,0.49581507401192965,Downregulated
Feature0949,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature0949,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,136047710.59076,124860201.68268733,0.9177677532426445,-0.12379897788899259,0.2669163227440811,0.5274244238002164,Downregulated
Feature0948,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,2062930.524516235,3630818.1627902933,1.7600292979530825,0.8155994445783769,0.43492073120066976,0.6304664863141491,Upregulated
Feature0947,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,54742939.1825521,39438157.41708197,0.7204245516589264,-0.47308074657902066,0.03597123106448118,0.3917457709388165,Downregulated
Feature0946,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,12644904.801351143,13895621.884859636,1.0989107552138195,0.136074226834502,0.87626760122211,0.9384420136440267,Upregulated
Feature0945,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature0945,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,117423063.83678867,106180064.96887366,0.9042522099104642,-0.14520287618605118,0.4195441985824283,0.6153314912542281,Downregulated
Feature0944,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1139479.0103012617,864020.09904087,0.758258898347268,-0.39923757157151435,0.45516144806474756,0.6491254026399449,Downregulated
Feature0943,NA,C15 H18 O11,374.08496,NA,NA,Feature0943,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,165646.09829430765,916593.197275533,5.5334427234561145,2.468177356526548,0.10390136169906374,0.4501055128430483,Upregulated
Feature0942,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,309053.7111769317,221406.644332096,0.7164018302480174,-0.4811590717924589,0.5356845845837932,0.7118993857057889,Downregulated
Feature0941,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1237004.3372259533,1052233.6402927067,0.850630518121218,-0.23339547934018548,0.37237428769323333,0.5859802956406841,Downregulated
Feature0940,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,92690701.7210103,89311925.08707364,0.9635478362856025,-0.05357180256577305,0.6553752715858969,0.7898292746717255,Downregulated
Feature0939,NA,C10 H21 N O9,299.12162,NA,NA,Feature0939,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,58063619.44972934,59079168.3961398,1.0174902797316951,0.025015012231214467,0.8967252944783676,0.9497007697011406,Upregulated
Feature0938,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature0938,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,16666554.512271801,17904976.252848532,1.0743058044579559,0.10340471937269806,0.15514259337755493,0.47268226304818617,Upregulated
Feature0937,NA,C16 H27 N O14,457.14329,NA,NA,Feature0937,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,74687345.3798503,68056161.59265676,0.9112140918455706,-0.1341380365172395,0.24655158215132528,0.5073945532162878,Downregulated
Feature0936,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,42707879.14463803,40477595.119915836,0.947778160157077,-0.07737867784605429,0.7503448030094924,0.8573186038458762,Downregulated
Feature0935,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,9098774.128838006,5700049.61895518,0.6264634705997616,-0.674697707161528,0.23767663967213778,0.5073945532162878,Downregulated
Feature0934,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,15838425.647982366,14296834.135058034,0.9026676295241053,-0.1477332229135889,0.2840354955321577,0.5419860986174846,Downregulated
Feature0933,NA,C23 H41 N,331.32396,NA,NA,Feature0933,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,77912679.68472274,107235689.66423923,1.3763573541325163,0.46085509656657386,0.5255601193654954,0.7036735727065463,Upregulated
Feature0932,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,27249440.2400305,27820663.936317835,1.0209627680882847,0.02993025576145944,0.8209828669920257,0.9015260366328117,Upregulated
Feature0931,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,644848.628686271,411048.058854797,0.6374334077320002,-0.6496534624891035,0.272471991409058,0.5335315433873701,Downregulated
Feature0930,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1441708.8673649335,1411525.11608631,0.9790639067554662,-0.03052506248424366,0.6500923926789385,0.7882293181406611,Downregulated
Feature0929,NA,C9 H15 N O7,249.08488,NA,NA,Feature0929,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,55232691.10674067,52339537.3370648,0.9476188157465537,-0.07762125013494105,0.07589079341013173,0.4407379248873613,Downregulated
Feature0928,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,13016090.632738434,13293102.2815267,1.021282246459741,0.030381631441309707,0.8462310288553748,0.9182506908856194,Upregulated
Feature0927,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,2060669.5478419317,1876825.1820566067,0.9107841594602789,-0.13481889483446943,0.8774365033996476,0.9384420136440267,Downregulated
Feature0926,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,846000.8969849123,551667.5993330766,0.6520886695264522,-0.6168599427188134,0.09349145399901769,0.4408310796245394,Downregulated
Feature0925,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature0925,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,6790724.174037657,8440479.492827954,1.2429424721884086,0.31375952486254527,0.5133163534495477,0.691405700564697,Upregulated
Feature0924,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,9668391.044782337,8733198.319977904,0.90327317953186,-0.1467657227368848,0.30758459086257484,0.559635581528333,Downregulated
Feature0923,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,444782.8601465743,387444.365474465,0.871086546245928,-0.19911203090028595,0.33498053981330067,0.5724452615273762,Downregulated
Feature0922,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,2041972.7939920002,2087778.8644312134,1.0224322628460019,0.032005266352116056,0.9195074135570471,0.961497966459466,Upregulated
Feature0921,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,98180714.3545662,91720757.81602643,0.934203406636353,-0.09819138885393222,0.20877583481576184,0.48745712214463777,Downregulated
Feature0920,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1439665.7944204947,899386.0736545507,0.624718651467703,-0.6787214915434507,0.39724750430991684,0.6085882694157574,Downregulated
Feature0919,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,444455.30846100696,290755.90102113265,0.6541847863802516,-0.6122298861682606,0.07409943076749125,0.4407379248873613,Downregulated
Feature0918,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1371534.2732491468,829395.4305805647,0.604720893059229,-0.7256586700367671,0.04205589516823405,0.3917457709388165,Downregulated
Feature0917,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1708755.5566792067,1321527.4932112799,0.7733859228990803,-0.3707395900328652,0.11001276056207117,0.45172120667857957,Downregulated
Feature0916,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,859490.0345610153,660738.644971152,0.7687566096198245,-0.37940118548340707,0.3021687368160464,0.5561250522748177,Downregulated
Feature0915,NA,C5 H13 O6 P,200.04503,NA,NA,Feature0915,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,1590429.153727167,2443031.757548297,1.5360833595278718,0.6192565097532347,0.22294911895136416,0.49581507401192965,Upregulated
Feature0914,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,86844989.07442953,59783645.440788634,0.6883948754896121,-0.538691737098498,0.11992417086860965,0.4627741841989286,Downregulated
Feature0913,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,3615491.7812195,2784278.3191968566,0.7700967081877098,-0.3768884651031757,0.06860318479876189,0.437345303092107,Downregulated
Feature0912,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,18417834.180175565,16937287.604011767,0.9196134267645097,-0.12090056468907484,0.28977399819492633,0.547874631887935,Downregulated
Feature0911,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,429532.241832781,448681.8365952873,1.0445824385168305,0.06292635448846853,0.8782211357631267,0.9384420136440267,Upregulated
Feature0910,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,79645605.7314965,78484941.27021924,0.9854271374972007,-0.02117889257607142,0.868192048710534,0.9339515615083597,Downregulated
Feature0909,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,47935435.14028043,48380556.436470665,1.0092858507466889,0.013334833561894488,0.9723198042192193,0.983717601743881,Upregulated
Feature0908,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,3529147.7979301866,5031830.659406973,1.4257919893176751,0.5117635204427564,0.23432635735297466,0.5046337292707055,Upregulated
Feature0907,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,64183298.8194623,39067420.26284607,0.6086851405493613,-0.7162319482558247,0.40862929230239103,0.6115057027381818,Downregulated
Feature0906,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,752726.3009359833,416846.83092892537,0.5537827367139875,-0.8526080141787498,0.10818274260053043,0.45172120667857957,Downregulated
Feature0905,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,252486.680563409,204890.76056292866,0.8114913630522098,-0.30135235507167,0.11407535278448071,0.4604048410941991,Downregulated
Feature0904,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,5015851.68143896,2848416.11377046,0.5678828431691783,-0.8163347690528219,0.45531345087133385,0.6491254026399449,Downregulated
Feature0903,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature0903,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,2579656.37135459,1759500.6011881432,0.682067821406857,-0.5520128941385907,0.010881062951969505,0.3605734563057726,Downregulated
Feature0902,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,1124943.7013810533,1048921.7704908168,0.9324215684776873,-0.10094571807405263,0.4647951644231958,0.6526910819559771,Downregulated
Feature0901,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,20452839.0236054,19542305.23381237,0.9554813007259213,-0.06570045571284644,0.35088074664569524,0.5724452615273762,Downregulated
Feature0900,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,50119042.0826584,61899881.269780435,1.2350571498891096,0.3045778012868535,0.5560263830699814,0.7237768804931469,Upregulated
Feature0899,NA,C12 H18 O9,306.09516,NA,NA,Feature0899,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,65554909.54377624,69719125.03842503,1.06352255725207,0.08885063310166454,0.5778478140544963,0.7359196905438647,Upregulated
Feature0898,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,7402839.083799327,21241716.3320894,2.869401332601655,1.5207497666638896,0.08185701901868267,0.4407379248873613,Upregulated
Feature0897,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,11336616.718410766,8539280.29068459,0.7532476842775079,-0.4088037623633304,5.651864769960647e-4,0.10568987119826409,Downregulated
Feature0896,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,40712658.889085166,37040225.472015865,0.9097962767041516,-0.13638456440315413,0.12129099756112836,0.4627741841989286,Downregulated
Feature0895,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3644703.72562664,3277312.9961434365,0.8991987395573456,-0.1532880816101528,0.3716432255512736,0.585966913959326,Downregulated
Feature0894,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,26635544.0935372,24375539.167053066,0.9151507880391864,-0.12791862118094655,0.43856502418355375,0.6326672985317091,Downregulated
Feature0893,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,633034.6766109806,589067.2567061047,0.9305450056223457,-0.10385216725957556,0.5693398006677698,0.7325679545289423,Downregulated
Feature0892,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,824901.308032644,665019.2107752421,0.8061803324827861,-0.3108255071531653,0.24745489255564723,0.5073945532162878,Downregulated
Feature0891,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,11712540.714878734,4966564.085405733,0.42403814904964066,-1.2377340306439224,2.573697507477917e-4,0.07219221508475557,Downregulated
Feature0890,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,8113532.85105486,11478604.15813734,1.4147479733991561,0.5005450707876489,0.0728798574519827,0.4407379248873613,Upregulated
Feature0889,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,23389641.0427801,18906022.466585502,0.8083075080975388,-0.30702384645412745,0.00976010961359715,0.3605734563057726,Downregulated
Feature0888,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,19191628.670436766,15638413.855995167,0.8148560043830436,-0.2953829559322883,0.015838275551853184,0.3605734563057726,Downregulated
Feature0887,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,1871725.94777091,1512578.8422885,0.8081198233586876,-0.30735887152817654,0.23544035998403282,0.5060614634139555,Downregulated
Feature0886,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,33125513.7628025,29793191.987214632,0.8994031670135236,-0.15296013079742202,0.19783102368681113,0.48745712214463777,Downregulated
Feature0885,NA,C6 H15 N O6,197.08997,NA,NA,Feature0885,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,52437880.899835035,48075952.4862597,0.9168172256634982,-0.12529394439437394,0.22612582929340966,0.4984541855937243,Downregulated
Feature0884,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,62733354.099269,50105494.3787537,0.7987058096633407,-0.3242638872229362,0.24219397072044926,0.5073945532162878,Downregulated
Feature0883,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,57011827.33419203,50934689.794410534,0.8934056699470705,-0.16261268423705555,0.21925829470219418,0.49414252020044086,Downregulated
Feature0882,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,3978568.610931793,3051353.13070649,0.7669474700831799,-0.38280032712755524,0.11823412408788593,0.4627741841989286,Downregulated
Feature0881,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,71879923.28509137,62498328.915404566,0.8694824098173093,-0.20177125369941437,0.1523997364784331,0.47268226304818617,Downregulated
Feature0880,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,13290760.658458633,11190910.678888267,0.8420067870055308,-0.2480962326886137,0.03975863574719325,0.3917457709388165,Downregulated
Feature0879,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,200860.53638430368,173928.70427383567,0.8659177527090752,-0.20769809463950564,0.07673598351201397,0.4407379248873613,Downregulated
Feature0878,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature0878,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,16913049.824625168,19707904.19777297,1.1652483970737513,0.22063752829385733,0.29476688095181186,0.5514055908137371,Upregulated
Feature0877,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,1261527.3443194525,896257.207860008,0.7104540475446497,-0.4931867565008132,0.3867901987994308,0.5985911766247742,Downregulated
Feature0876,NA,C30 H46 O11,582.30426,NA,NA,Feature0876,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,815530.0068930946,705439.3764443366,0.8650072596737823,-0.20921585410168317,0.22729049857496375,0.4990605469188433,Downregulated
Feature0875,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,38002190.3913348,39924772.01591287,1.050591337098728,0.07120159356849334,0.34708456160079876,0.5724452615273762,Upregulated
Feature0874,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature0874,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,28189670.2007511,25914680.18965943,0.9192970334562107,-0.12139700980832532,0.3470867068283774,0.5724452615273762,Downregulated
Feature0873,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3433896.1366668968,2357841.85481841,0.6866374989160399,-0.5423794464140236,0.43463580044413097,0.6304664863141491,Downregulated
Feature0872,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,1316231.323093038,1099070.59075232,0.8350132468885425,-0.2601290097931111,0.5955754282679994,0.7533659870537714,Downregulated
Feature0871,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,135056.585521799,127686.010686658,0.945426024161174,-0.08096351746441272,0.4107945476848489,0.611898054554379,Downregulated
Feature0870,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,1697207.07753447,1834556.2804114732,1.0809266027080975,0.11226856423441349,0.7628384948242608,0.8654244602556326,Upregulated
Feature0869,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,227667.71460292934,183354.694897075,0.8053609850516584,-0.3122925109024886,0.05104453301324646,0.42423678559897127,Downregulated
Feature0868,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,5319417.6819947995,5092102.40693609,0.957266887345935,-0.06300688870162707,0.7599117200348013,0.86385101304868,Downregulated
Feature0867,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,279092.18344432965,344554.618134744,1.2345548839187468,0.3039909749961481,0.5707736943448558,0.7327323627630757,Upregulated
Feature0866,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,48976503.504833035,51239150.30838,1.0461986185543786,0.06515677013326567,0.7566596267594379,0.861900610379786,Upregulated
Feature0865,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,5363281.213117046,5027393.969299607,0.9373728077140622,-0.09330515066257607,0.4926833202604627,0.6766864944350365,Downregulated
Feature0864,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,386547.4316898507,333880.35652555834,0.8637500320877822,-0.2113142357912321,0.3195633126254422,0.5655363355926596,Downregulated
Feature0863,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,279438.3305880763,220004.864451184,0.7873109747978563,-0.3449945059347784,0.5450650799121284,0.7186404461356146,Downregulated
Feature0862,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,1960514.65815044,1171360.857511308,0.5974762048534623,-0.7430468375655175,0.044870503668804795,0.393943055526956,Downregulated
Feature0861,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature0861,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1195966.8949462266,1107386.581915609,0.9259341429893004,-0.11101850935164602,0.3464804586185429,0.5724452615273762,Downregulated
Feature0860,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,567180.526752344,450727.70752627536,0.7946812104201224,-0.33155186138628656,0.4156835639766248,0.615243020119386,Downregulated
Feature0859,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature0859,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,249144.39894437668,220930.33134466567,0.8867561634166619,-0.1733906422109681,0.346049793293769,0.5724452615273762,Downregulated
Feature0858,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,10337787.385414984,7850230.394147296,0.7593723977359754,-0.39712053518918444,0.2430942005946364,0.5073945532162878,Downregulated
Feature0857,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,660447.873569663,899394.7893940513,1.3617952686150703,0.44550982584989296,0.6684826373701166,0.7993886055675886,Upregulated
Feature0856,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,6282054.171945724,6049144.882285563,0.9629246607422963,-0.05450516891144044,0.6038417401673579,0.758690293916882,Downregulated
Feature0855,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,426853.1084610486,555836.639545611,1.302173109502686,0.38092125159107165,0.40897905639913534,0.6115057027381818,Upregulated
Feature0854,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4928553.518792204,4521161.69674903,0.9173404893565993,-0.12447077640896824,0.540555191608227,0.7152157134250362,Downregulated
Feature0853,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,196327.51139934832,190887.34776989868,0.9722903652642759,-0.040540869565496296,0.9077631308526156,0.9532692248087129,Downregulated
Feature0852,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,5431976.10191679,5319901.777182487,0.9793676697703521,-0.030077523337154254,0.8201231998706482,0.9015260366328117,Downregulated
Feature0851,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,1848889.0316154135,1414661.05883734,0.7651411386227548,-0.3862022017095134,0.2633094468889959,0.5265330007344392,Downregulated
Feature0850,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,11515918.656542568,7722933.755700953,0.6706311485895485,-0.5764086018062947,0.009489911760081009,0.3605734563057726,Downregulated
Feature0849,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,319397.69124432,365052.8145891367,1.1429413067043532,0.19275131894983966,0.5216389436724072,0.7000943717708622,Upregulated
Feature0848,NA,C18 H33 N O15,503.18514,NA,NA,Feature0848,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,61062138.3692113,55526745.608126566,0.9093481999006476,-0.13709527012635445,0.23962981966308983,0.5073945532162878,Downregulated
Feature0847,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,11393707.1008844,10216056.31804093,0.896640244266762,-0.15739884098047813,0.08328302829795736,0.4407379248873613,Downregulated
Feature0846,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,49573428.03407063,44502112.95746034,0.8977009402471642,-0.15569318876420127,0.09709049669729637,0.4438331226509661,Downregulated
Feature0845,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,26200473.92807513,23978585.799086034,0.9151966435764266,-0.12784633375065335,0.24171209237786045,0.5073945532162878,Downregulated
Feature0844,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,3191673.7664339067,2811169.91578349,0.8807823485432353,-0.1831425382515558,0.1686661297899429,0.48569146941833746,Downregulated
Feature0843,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature0843,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,522201.69096658035,489154.5380561047,0.9367157297991389,-0.09431680306768536,0.5433432455460976,0.7172130841208488,Downregulated
Feature0842,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,557768.213760199,430146.0749237593,0.7711914453208547,-0.3748390467707736,0.23194610796306314,0.5030930259325901,Downregulated
Feature0841,NA,C14 H31 N O,229.24056,NA,NA,Feature0841,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,23575581.38074879,31192065.618982535,1.3230666559278648,0.4038857462380306,0.5892019419298076,0.7461629821295809,Upregulated
Feature0840,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,39688702.18317257,35632840.47521907,0.8978081548437952,-0.15552089449125417,0.6253912985187713,0.7770642712492374,Downregulated
Feature0839,NA,C12 H19 N O7,289.11624,NA,NA,Feature0839,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,35760203.05906457,32316089.435083736,0.9036886446564008,-0.14610230032543592,0.5367797507193381,0.7118993857057889,Downregulated
Feature0838,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,6709993.74790853,5552715.604377894,0.8275291770739199,-0.2731179154414967,0.5734982749407459,0.7335520513857691,Downregulated
Feature0837,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1602253.1467787134,1505864.32497809,0.9398417022962878,-0.08951031101591395,0.6545429886361368,0.7896744443545651,Downregulated
Feature0836,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature0836,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,3348322.9439955535,3493857.82361779,1.0434650068277374,0.06138221973819728,0.560193582095536,0.7237768804931469,Upregulated
Feature0835,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,264517.02725676,205699.20127363165,0.7776406812328366,-0.36282440130673005,0.10197762968239829,0.4501055128430483,Downregulated
Feature0834,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature0834,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,1754755.0789044467,1975488.4296247067,1.1257915440017254,0.17093971704852198,0.3150731638256426,0.5614889991100109,Upregulated
Feature0833,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,776033.9626294724,589072.1592949231,0.759080385217861,-0.39767542240291137,0.20093080748075234,0.48745712214463777,Downregulated
Feature0832,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,3203578.50235753,2887661.212085023,0.9013861249099963,-0.1497828521533771,0.6973849093804874,0.8159185279717485,Downregulated
Feature0831,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,27519243.895486202,26522287.6328037,0.9637723962740842,-0.05323561392648253,0.38967057817001655,0.6007194466920363,Downregulated
Feature0830,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,25197946.971592367,22758192.211175736,0.9031764467491277,-0.14692023123138412,0.2796981213462602,0.5393007678750934,Downregulated
Feature0829,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature0829,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,521471.07133226667,420314.9510511457,0.8060177719491036,-0.311116445687255,0.20326155355468067,0.48745712214463777,Downregulated
Feature0828,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,24291303.512729768,22669551.463050302,0.933237339493552,-0.0996840631498153,0.17982250871493063,0.48745712214463777,Downregulated
Feature0827,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,4749093.776897623,6411534.289239957,1.3500542609685704,0.4330173927998881,0.155260467935933,0.47268226304818617,Upregulated
Feature0826,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1497182.6275097732,1105850.3223501197,0.7386208616309242,-0.43709408424412655,0.12836121634764058,0.4627741841989286,Downregulated
Feature0825,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,302473.51109740534,260846.19112083665,0.8623769736875786,-0.21360943765761065,0.13303300205530402,0.46582465100243564,Downregulated
Feature0824,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,803028.900063355,781979.9566340863,0.973788062387782,-0.03832028008799304,0.9304712201109147,0.9674295353109107,Downregulated
Feature0823,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,1632082.0936909167,1423840.80485619,0.8724075892752468,-0.1969257745165183,0.35493066114380345,0.5729208247262728,Downregulated
Feature0822,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,584425.353127192,410593.483361061,0.7025593280031797,-0.5093080352450002,0.06417297252546714,0.43620489220914954,Downregulated
Feature0821,NA,C12 H19 N O8,305.11113,NA,NA,Feature0821,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,290647.30064726167,335570.470728213,1.1545624885588444,0.20734625842537568,0.6005586973814273,0.7562591004062418,Upregulated
Feature0820,NA,C18 H33 N O15,503.18519,NA,NA,Feature0820,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,46107314.789003,41383482.9355158,0.8975470188384539,-0.15594057704552838,0.32870198213205876,0.5724452615273762,Downregulated
Feature0819,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,975565.0661126436,2486570.91704717,2.5488519458322405,1.3498475745303569,0.03088386846024533,0.3917457709388165,Upregulated
Feature0818,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,6928110.915093566,6010606.909477317,0.8675679392462702,-0.20495135532237257,0.3455875428743887,0.5724452615273762,Downregulated
Feature0817,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,6824730.14346831,10141169.462178446,1.4859443888611734,0.571380124345232,0.0701564300749385,0.4407379248873613,Upregulated
Feature0816,NA,C7 H17 N O6,211.10558,NA,NA,Feature0816,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,895191.3768788001,719638.2164928347,0.8038931507606183,-0.3149243361595082,0.5605722897937119,0.7237768804931469,Downregulated
Feature0815,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,754526.041713502,920773.4820155144,1.2203336016401374,0.28727559011730314,0.23149877402626215,0.5030930259325901,Upregulated
Feature0814,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,5866140.787961236,5162318.26724389,0.8800194972882746,-0.18439260712663214,0.6461533402023352,0.7854648404193066,Downregulated
Feature0813,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1769640.1518024108,1191088.418290656,0.6730681472600578,-0.571175511690998,0.3654004487728472,0.5815309269831697,Downregulated
Feature0812,NA,C32 H36 O10,580.23105,NA,NA,Feature0812,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,285673.22228330333,251843.95520580967,0.8815805457469688,-0.18183570725783924,0.30264937247195034,0.5561250522748177,Downregulated
Feature0811,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1671685.1242804767,1655021.8367402568,0.990032041741478,-0.014452877055237307,0.9444376955915226,0.9730570197003565,Downregulated
Feature0810,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,755011.9525937546,520067.47249333997,0.688820184510602,-0.5378006762137395,0.08444412317781112,0.4407379248873613,Downregulated
Feature0809,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1009620.6819430649,840545.884545694,0.8325363174296527,-0.26441488716852235,0.1546061469878361,0.47268226304818617,Downregulated
Feature0808,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature0808,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,446699.1211565877,380487.38676462363,0.8517755436354353,-0.23145478737807235,0.13048633361629997,0.4627741841989286,Downregulated
Feature0807,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,318459.24571808235,236356.67871185133,0.742188150885364,-0.4301431264514688,0.48427922269591617,0.6708164047713802,Downregulated
Feature0806,NA,C9 H19 N O3,189.13649,NA,NA,Feature0806,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,816276.8861901283,784043.0873062987,0.9605111948786436,-0.058125666106625236,0.815771379514175,0.8996655060370997,Downregulated
Feature0805,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,2376712.5374144735,2456240.6642549764,1.0334613991337036,0.0474845035980065,0.5746706705483293,0.7335520513857691,Upregulated
Feature0804,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,573390.5860532296,524854.8596957827,0.9153531161166618,-0.1275996951032338,0.8426393840609949,0.9152385178281087,Downregulated
Feature0803,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,1718357.0904256634,891184.6820472283,0.5186260102819887,-0.9472335324218748,0.018678800663704254,0.376638701722027,Downregulated
Feature0802,NA,C11 H17 N O5,243.11065,NA,NA,Feature0802,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,613923.4171962527,663317.7217505587,1.0804567852776923,0.11164137028871036,0.8115695270711539,0.8996655060370997,Upregulated
Feature0801,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,30776908.310486335,39737439.46337397,1.2911446160378166,0.3686506003010743,0.08509887449247287,0.4407379248873613,Upregulated
Feature0800,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,236830.50015266868,257444.63058300666,1.0870417045821776,0.12040729072374615,0.7410605095785043,0.8509437710669626,Upregulated
Feature0799,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,25484262.078879833,19791287.623312302,0.7766082283274899,-0.3647411019026554,0.5554944765245415,0.7237768804931469,Downregulated
Feature0798,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3642220.8280601697,3302681.1165585965,0.9067767366312024,-0.14118071569365587,0.806416891890172,0.8976188022825129,Downregulated
Feature0797,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,339771.54080758436,251471.646253279,0.7401198041942236,-0.43416927424424423,0.704969445999241,0.8222626959969398,Downregulated
Feature0796,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1680999.3070683063,1745713.8324480867,1.0384976514313047,0.054497953522723123,0.9233937630923056,0.9636251321296494,Upregulated
Feature0795,NA,C7 H17 N O6,211.10569,NA,NA,Feature0795,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,26037651.067754768,26032154.811405167,0.9997889112064948,-3.0456890224925655e-4,0.9990736480994264,0.9990736480994264,Downregulated
Feature0794,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,13723947.137441548,12621051.029752133,0.9196371061004379,-0.12086341688358933,0.767526113316036,0.8698629284248408,Downregulated
Feature0793,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,38988212.59101653,39515229.34810707,1.0135173356783216,0.019370765551976685,0.947460897113981,0.9745386254697084,Upregulated
Feature0792,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,3572795.4412403433,3252204.37870973,0.910268844717481,-0.13563539170970562,0.4021635559946913,0.6115057027381818,Downregulated
Feature0791,NA,C15 H27 N O5,301.18898,NA,NA,Feature0791,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,975893.496438995,9429412.165220607,9.662337334584397,3.2723722214759023,0.15556544282656282,0.47268226304818617,Upregulated
Feature0790,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,5674821.389879207,7715066.412156143,1.359525856781259,0.4431035901970656,0.5532801032548371,0.7237768804931469,Upregulated
Feature0789,NA,C31 H40 O6,508.28264,NA,NA,Feature0789,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,163936.69601380534,166695.63585676433,1.0168293000288762,0.024077507443442493,0.9535237903861977,0.9767885471671011,Upregulated
Feature0788,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1445705.1334887054,1042224.5038987563,0.7209108411918762,-0.4721072500178139,0.42801417254401486,0.6236777942784216,Downregulated
Feature0787,NA,C6 H9 O7 P,224.00856,NA,NA,Feature0787,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,5046907.790919157,4963386.835141043,0.9834510636535916,-0.02407482884088341,0.9035942939018737,0.9518635835741798,Downregulated
Feature0786,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,174643.20176644868,150927.69811735366,0.8642059730397643,-0.21055289260462728,0.18915348672751045,0.48745712214463777,Downregulated
Feature0785,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,6292423.318308147,6299199.9491540305,1.0010769508825268,0.0015528756621026932,0.9792955158977494,0.9863281587408211,Upregulated
Feature0784,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,36021324.533504464,34933304.7543521,0.9697951201616597,-0.0442481005223566,0.6890352147174091,0.8103781128808827,Downregulated
Feature0783,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature0783,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,185017.536262353,162927.37848199534,0.8806050592467406,-0.18343296202611922,0.29946768762381926,0.555822019398608,Downregulated
Feature0782,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,7418923.680162467,6716317.1714011,0.9052953583226535,-0.1435395375324535,0.029237716646731877,0.39036770986176245,Downregulated
Feature0781,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature0781,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,12913965.466295134,11672247.651701234,0.9038468998670681,-0.1458496756853288,0.20222588013591453,0.48745712214463777,Downregulated
Feature0780,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,195272.73870754533,172354.674780291,0.882635619908122,-0.1801101245643283,0.013077611509322764,0.3605734563057726,Downregulated
Feature0779,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,554508.600749061,512954.117646715,0.9250607059183359,-0.11238005114640569,0.5166999505620277,0.6951287104683395,Downregulated
Feature0778,NA,C11 H14 N O P S,239.05347,NA,NA,Feature0778,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,297589.441172131,261018.75599020798,0.8771102730060578,-0.1891698607488228,0.06803552240338785,0.43620489220914954,Downregulated
Feature0777,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,31882099.134638432,28373429.2805728,0.8899485934333093,-0.16820609155077576,0.40412046110341604,0.6115057027381818,Downregulated
Feature0776,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature0776,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,18261079.764596634,14649241.455522867,0.8022111312346295,-0.31794611020392105,0.023191718318766687,0.39036770986176245,Downregulated
Feature0775,NA,C4 H11 O6 P,186.02935,NA,NA,Feature0775,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,420972.9875194673,339035.21997241303,0.8053609852027259,-0.3122925106318717,0.051044533026614186,0.42423678559897127,Downregulated
Feature0774,NA,C13 H19 N O6,285.1213,NA,NA,Feature0774,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,321992.2293904143,264676.54035794537,0.8219966701029486,-0.28279554530606493,0.14759762727714998,0.47268226304818617,Downregulated
Feature0773,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,26694435.252773635,24462407.69412463,0.9163860356095345,-0.12597262065155465,0.6354232109118048,0.780256870266987,Downregulated
Feature0772,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,19230104.084272366,19858236.6197519,1.0326640216156324,0.046370948112364176,0.6390874008693057,0.780256870266987,Upregulated
Feature0771,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1093729.1022782768,863383.6213077831,0.7893943934648207,-0.3411818221083645,0.3695815281903361,0.585966913959326,Downregulated
Feature0770,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1178913.9305656035,1048814.8994688124,0.8896450133264826,-0.16869830900673458,0.6773668256079268,0.8028826089840505,Downregulated
Feature0769,Furan,C4 H4 O,68.02622,Other,NA,Furan,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,37378657.795414634,28042571.6695084,0.7502294978860498,-0.41459610619178916,0.23219783536284808,0.5030930259325901,Downregulated
Feature0768,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,660325.1710654927,586825.0962824513,0.8886910903843896,-0.17024607045303644,0.4019264907625048,0.6115057027381818,Downregulated
Feature0767,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,9771923.664542804,8508911.923796669,0.8707509612125867,-0.19966793449900305,0.40592120821985556,0.6115057027381818,Downregulated
Feature0766,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,2006588.5804259533,2109971.222910627,1.051521594158942,0.07247847771222853,0.8739874285814531,0.9374893832393789,Upregulated
Feature0765,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,13734239.947110966,9987336.44689697,0.7271852308796916,-0.4596051961708011,0.28512842474287686,0.5431478651298944,Downregulated
Feature0764,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,357171.680702612,547600.4599337163,1.5331575528510588,0.6165059612089383,0.14838954316312505,0.47268226304818617,Upregulated
Feature0763,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,31124954.5586999,30954396.99408747,0.9945202308877024,-0.007927375709195064,0.9369928259020064,0.9698394378801211,Downregulated
Feature0762,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,2843129.4338896433,2123849.2439072635,0.7470110993158889,-0.42079841571618704,0.5286159695153307,0.7069214753232433,Downregulated
Feature0761,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,18458496.259493034,17629343.232992034,0.9550801422366909,-0.06630629791034295,0.3302427299127018,0.5724452615273762,Downregulated
Feature0760,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,245635.05160487833,151679.82620555867,0.6175007402833802,-0.6954872286313081,0.30845101780171585,0.559635581528333,Downregulated
Feature0759,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,39291050.93179597,33182463.395705935,0.8445298002668921,-0.24377976370353316,0.08933657839268522,0.4407379248873613,Downregulated
Feature0758,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,678690.713937271,595398.1160846177,0.8772745874634852,-0.1888996171336259,0.18161816683875667,0.48745712214463777,Downregulated
Feature0757,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,510378.116178129,483776.6539479566,0.9478789129334689,-0.07722532148951007,0.8211761224944149,0.9015260366328117,Downregulated
Feature0756,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,14063901.859918233,12840406.131676333,0.9130045317132913,-0.13130607381908446,0.2900729110545702,0.547874631887935,Downregulated
Feature0755,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0755,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,126057.80599777566,112213.09392317633,0.8901717195137949,-0.1678444273540874,0.28882391891306536,0.547399386858884,Downregulated
Feature0754,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,3345211.027681433,2562674.2866064166,0.7660725333620004,-0.3844470988630228,0.19570135257604654,0.48745712214463777,Downregulated
Feature0753,NA,C18 H28 O,260.21405,NA,NA,Feature0753,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1768741.7702859566,1336140.6142572968,0.7554187031164419,-0.4046515915444003,0.3141470465568924,0.5612627169376326,Downregulated
Feature0752,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,139226.61685653034,118600.90999725567,0.8518551457690813,-0.2313199675438758,0.153982834449311,0.47268226304818617,Downregulated
Feature0751,NA,C13 H18 O9,318.09513,NA,NA,Feature0751,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,179286.51388454967,133277.67644191533,0.7433781468233499,-0.4278318171436839,0.16704541462820233,0.48555687878974874,Downregulated
Feature0750,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,5923251.241924027,5698383.84051549,0.962036491071499,-0.05583647689056282,0.6426667437434244,0.7830134576033835,Downregulated
Feature0749,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,8807651.395707041,8297189.671356954,0.9420433778068359,-0.0861346024527352,0.34482243989560746,0.5724452615273762,Downregulated
Feature0748,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,8047105.4273726335,7196565.12316949,0.8943048140875615,-0.1611614527166302,0.20759910351906916,0.48745712214463777,Downregulated
Feature0747,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature0747,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,706968.1721275783,557005.0775061013,0.7878785770932629,-0.3439547871895145,0.24917504351352454,0.5073945532162878,Downregulated
Feature0746,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature0746,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,5697574.623247483,5913993.32218514,1.0379843553175445,0.05378469930669236,0.6591983697552133,0.7927337308310282,Upregulated
Feature0745,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,251455.8414065597,219177.04763576167,0.8716323566386796,-0.19820834187581754,0.21974400486159815,0.49414252020044086,Downregulated
Feature0744,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,2052965.5645562932,1278051.5232134906,0.6225391917324806,-0.6837634304965643,0.2556590739394711,0.5160466413580144,Downregulated
Feature0743,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,33041924.0120291,30444457.0975968,0.9213887510458932,-0.11811811026124765,0.14065614841629803,0.470482482651178,Downregulated
Feature0742,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,4376828.057351966,4813736.411425244,1.099823056411682,0.13727143632163927,0.1125884850506742,0.45604433294894026,Upregulated
Feature0741,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,4660408.525376697,3779988.641475477,0.8110852559154014,-0.3020745259173831,0.1593091444623789,0.47628186389725785,Downregulated
Feature0740,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,3634379.2028623065,6607929.180591487,1.8181727364572524,0.8624892700446212,0.236022189381016,0.5063420582896748,Upregulated
Feature0739,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,30265583.0060236,27545103.963588633,0.910113112908034,-0.135882233872478,0.48799986765153025,0.6742693443769489,Downregulated
Feature0738,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1113476.60638949,1164006.2304321732,1.0453800499738637,0.06402753229029151,0.6354992489595344,0.780256870266987,Upregulated
Feature0737,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,9938144.033073304,9189581.08875124,0.9246777927718787,-0.11297735385245546,0.3382910860767714,0.5724452615273762,Downregulated
Feature0736,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,7945140.374383593,7736619.119281896,0.9737548683502179,-0.03836945884819364,0.8733167291566395,0.9374893832393789,Downregulated
Feature0735,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,5863276.249135227,6258759.529209203,1.0674509034317299,0.09416971574322722,0.3152745716927869,0.5614889991100109,Upregulated
Feature0734,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,6905852.7436089935,5855255.86018222,0.8478686235528196,-0.23808735702377304,0.15576309959357207,0.47268226304818617,Downregulated
Feature0733,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0733,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,738859.2546654933,925770.9692573934,1.2529733686242062,0.3253557511624895,0.274128634666572,0.5339797362775934,Upregulated
Feature0732,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,1204882.2202326069,845154.0823091273,0.7014412430668678,-0.5116058347860241,0.06319680200564093,0.43620489220914954,Downregulated
Feature0731,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,590851.6711253431,498646.98696775635,0.8439461396766932,-0.2447771652686499,0.05837792098841602,0.43620489220914954,Downregulated
Feature0730,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,29839822.148557335,26007920.1736505,0.8715842890808886,-0.19828790379078723,0.20487939651004963,0.48745712214463777,Downregulated
Feature0729,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1392672.1943071033,1172290.3573356762,0.8417561305005635,-0.24852577166419557,0.5740940564811098,0.7335520513857691,Downregulated
Feature0728,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1584914.95758141,1270458.9618356,0.8015944046451099,-0.3190556567371323,0.05385677047809152,0.43364536838278145,Downregulated
Feature0727,NA,C29 H30 O10,538.18408,NA,NA,Feature0727,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,438371.88362302934,376410.431887211,0.8586555067726445,-0.2198486577675273,0.19213597674226063,0.48745712214463777,Downregulated
Feature0726,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,5932178.75375571,5917813.74057642,0.9975784591504099,-0.00349778169692592,0.9740892046415353,0.9837336522122435,Downregulated
Feature0725,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,6831979.20635503,6324657.478404934,0.9257430807930166,-0.11131623346956249,0.5474341189179119,0.7200716077677576,Downregulated
Feature0724,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,3885724.901843657,3568776.6742623835,0.918432664280765,-0.12275414216180051,0.0993477223498554,0.44747500090738557,Downregulated
Feature0723,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,1042659.7851592021,833077.9155364977,0.7989930439383891,-0.3237451518333276,0.31161330271800425,0.5612627169376326,Downregulated
Feature0722,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1872122.1709903767,3017782.39969648,1.6119580476417488,0.688814197186729,0.200622112412911,0.48745712214463777,Upregulated
Feature0721,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,6065306.2020954,6241436.44041585,1.0290389689245372,0.04129761703232418,0.91142645970688,0.9548277196929219,Upregulated
Feature0720,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,14750510.060271833,13186066.102501167,0.8939396704671082,-0.1617506237190423,0.12328083136593018,0.4627741841989286,Downregulated
Feature0719,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,26178734.977926366,23590647.563720167,0.9011377969031564,-0.150180363200984,0.6519401133997624,0.7882293181406611,Downregulated
Feature0718,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature0718,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,298024.7689005073,251806.82655934768,0.8449191236296569,-0.24311484286838875,0.043257626350317324,0.3917457709388165,Downregulated
Feature0717,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,187195.79672851833,172116.01439435032,0.919443798430808,-0.1211667031791305,0.46217044852030725,0.6519708164262784,Downregulated
Feature0716,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,186420.45533855967,235386.224493034,1.2626630702384416,0.3364697208798452,0.2302861428122206,0.5030930259325901,Upregulated
Feature0715,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature0715,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,316321.5829199657,259491.22070327698,0.8203399158157739,-0.2857062665618084,0.314074472788441,0.5612627169376326,Downregulated
Feature0714,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,1804937.3939488863,3386117.144738955,1.8760302468612082,0.9076830883249795,0.4606005227458419,0.6519708164262784,Upregulated
Feature0713,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,260105.89977943234,181661.04225898365,0.6984118484549205,-0.5178500606019121,0.4031089373927337,0.6115057027381818,Downregulated
Feature0712,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,16304360.898248734,14224141.698887233,0.8724133247329591,-0.19691628985670895,0.3243887023057031,0.5692978351524217,Downregulated
Feature0711,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,3734926.0630491534,2831109.89379166,0.7580096221450693,-0.39971193285924583,0.03876552884114281,0.3917457709388165,Downregulated
Feature0710,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,738815.6020886523,507452.447948571,0.6868458740096836,-0.5419416956228937,0.26682287718858505,0.5274244238002164,Downregulated
Feature0709,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature0709,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,823959.0011535106,1922845.3595239096,2.333666307221598,1.2225982836956328,0.2646863415861977,0.5265330007344392,Upregulated
Feature0708,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,858676.155998503,883527.6361050686,1.0289416212770779,0.041161130839009116,0.8285763168771105,0.9061773007075834,Upregulated
Feature0707,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,10884756.627879433,11613897.3495971,1.0669873242595151,0.09354303714025522,0.18602789409728399,0.48745712214463777,Upregulated
Feature0706,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,373407.53055880766,244037.70710813,0.6535425430304671,-0.6136469420780561,0.14720472377765295,0.47268226304818617,Downregulated
Feature0705,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,808085.0595871743,817137.565333395,1.011202416922354,0.016071816884899493,0.9493675606628271,0.9754490870546629,Upregulated
Feature0704,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature0704,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,6218097.5992263565,2627413.37101412,0.4225429609437166,-1.2428300638131518,0.35169226683007293,0.5724452615273762,Downregulated
Feature0703,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,233843.38749909165,199859.25263479166,0.8546713882836136,-0.22655826859928585,0.17497607815115668,0.4872332821127231,Downregulated
Feature0702,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,889940.6222656231,837484.397280728,0.9410564888572551,-0.08764676858797121,0.35696691570034605,0.5729208247262728,Downregulated
Feature0701,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,3319143.513505033,3051924.9281527665,0.9194917049338182,-0.12109153526355303,0.8986573822652542,0.9503238293134922,Downregulated
Feature0700,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,1267303.9384228888,1981014.2214629834,1.5631721494752708,0.6444766686242543,0.1031791419439853,0.4501055128430483,Upregulated
Feature0699,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,13741743.603315083,4698412.74001451,0.341908048617721,-1.5483197102435788,0.24297732597695468,0.5073945532162878,Downregulated
Feature0698,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature0698,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,130815.284971297,115849.13472563066,0.8855932603827591,-0.17528385204676916,0.2813255148053335,0.5395679104471525,Downregulated
Feature0697,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,155375.94801257233,130120.71597621233,0.8374572618259007,-0.2559125279819614,0.05543609432109339,0.43364536838278145,Downregulated
Feature0696,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature0696,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,732706.4007437327,624101.392831784,0.8517755436533524,-0.23145478734772523,0.130486333710972,0.4627741841989286,Downregulated
Feature0695,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,3506786.081231767,2240680.1380984667,0.6389554669703214,-0.6462127111641387,0.10934687998038818,0.45172120667857957,Downregulated
Feature0694,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,266237.52670687967,129579.90544786568,0.4867078921993204,-1.0388719260969062,0.0094411839662253,0.3605734563057726,Downregulated
Feature0693,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,7196905.83317737,7309437.533548706,1.0156361223808947,0.02238361228103023,0.938912141230823,0.9705851157097153,Upregulated
Feature0692,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature0692,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,1801006.59593359,5663525.94267428,3.1446447533627553,1.6528970468312063,0.033454451772039595,0.3917457709388165,Upregulated
Feature0691,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,330817.89164861,235015.21529170198,0.7104066050373471,-0.49328309961498673,0.1592291848565058,0.47628186389725785,Downregulated
Feature0690,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,5348269.470360413,4843326.569435037,0.9055876103992664,-0.14307387450225004,0.19788838373905043,0.48745712214463777,Downregulated
Feature0689,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,626965.3177098574,514070.666844784,0.8199347752161978,-0.2864189451746687,0.8140761258464785,0.8996655060370997,Downregulated
Feature0688,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,883925.9589856826,562985.9307316467,0.6369152585785364,-0.6508266598645156,0.6629584127425396,0.7955500952910476,Downregulated
Feature0687,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature0687,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,10518603.071222933,7891984.64135319,0.7502882833314897,-0.41448306591766837,0.020376871203251146,0.38750592356013197,Downregulated
Feature0686,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature0686,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,5881303.451163753,5299101.882771343,0.90100807189651,-0.15038806406175395,0.13256056991625767,0.46582465100243564,Downregulated
Feature0685,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,19116138.17858899,2271133.61137171,0.11880713511034832,-3.0733066133008182,0.18305917654951548,0.48745712214463777,Downregulated
Feature0684,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,5686913.720762993,4617912.563049117,0.8120243755745864,-0.3004050596040658,0.16690314186625427,0.48555687878974874,Downregulated
Feature0683,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,286193.8785860517,249530.04874411368,0.8718916350584553,-0.19777925722317294,0.29053957751632914,0.547874631887935,Downregulated
Feature0682,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,11894448.330559334,10194400.590752374,0.8570721657229634,-0.22251141009761444,0.1596270697818113,0.47628186389725785,Downregulated
Feature0681,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,2121683.3380467067,1751623.33904685,0.8255818894536135,-0.27651677175463335,0.4659378839690982,0.6534778822666603,Downregulated
Feature0680,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,3344441.8336585467,2166433.668007383,0.6477713698603875,-0.6264433894483242,0.24382799035222963,0.5073945532162878,Downregulated
Feature0679,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,894270.3683614474,1638695.0579033464,1.8324380588679154,0.8737644323703263,0.2740616285553036,0.5339797362775934,Upregulated
Feature0678,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,1121348.1241071913,583993.1396235604,0.5207955737104667,-0.9412109079296969,0.13916422599683645,0.470482482651178,Downregulated
Feature0677,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0677,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,149773.33451603932,128361.508146775,0.8570384612290827,-0.22256814541611616,0.08074090505264289,0.4407379248873613,Downregulated
Feature0676,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,597103.0386639477,866243.2364986567,1.4507433062757904,0.536792272317081,0.47319948367086295,0.6603092297246129,Upregulated
Feature0675,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,1895592.85056678,1952272.3018778667,1.0299006462775695,0.04250516844127721,0.8001037458491408,0.8932501520823243,Upregulated
Feature0674,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,456280.603312533,505443.113941583,1.107746220795136,0.14762740491059623,0.8162740509320565,0.8996655060370997,Upregulated
Feature0673,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0673,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,3682942.3969522766,3749669.9150085435,1.0181179912320881,0.025904767210448598,0.7760211808155941,0.8768336000756259,Upregulated
Feature0672,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,27837163.580399536,18129908.77993024,0.6512843425145411,-0.6186405515359681,0.13110337163576627,0.4627741841989286,Downregulated
Feature0671,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,694402.6788353933,581065.21131464,0.8367842305694507,-0.2570724310338886,0.4093055104780522,0.6115057027381818,Downregulated
Feature0670,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,3531095.7657043366,3280301.6432686867,0.9289755534609171,-0.10628746315000324,0.33685647799578466,0.5724452615273762,Downregulated
Feature0669,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,11200632.979326833,10023112.565699339,0.894870190300775,-0.1602496744007153,0.08634296893357524,0.4407379248873613,Downregulated
Feature0668,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0668,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,275625.0228578233,239838.07969087033,0.8701607611823652,-0.20064613308127546,0.17356219721786617,0.4872332821127231,Downregulated
Feature0667,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0667,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,18837948.916623868,15618726.423637433,0.8291097132052642,-0.27036507371616386,0.10821950062469105,0.45172120667857957,Downregulated
Feature0666,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0666,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,16230741.6005277,14460214.259708,0.8909151914067724,-0.16663999059273585,0.24452299468941008,0.5073945532162878,Downregulated
Feature0665,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0665,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,2713860.3943502265,2817181.480736037,1.0380716291084489,0.053905996098644,0.7432485700941385,0.8509437710669626,Upregulated
Feature0664,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1219638.3208266334,1066786.513907311,0.8746744798771786,-0.19318189353606605,0.06355368218895095,0.43620489220914954,Downregulated
Feature0663,NA,C9 H19 N O9,285.106,NA,NA,Feature0663,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,5298263.861917097,4471034.600350377,0.8438678625440524,-0.24491098336828432,0.20902292699609878,0.48745712214463777,Downregulated
Feature0662,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0662,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,15865821.530380033,15217651.361768434,0.9591467629097884,-0.06017651017350117,0.6514650034074567,0.7882293181406611,Downregulated
Feature0661,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,392722.04917315766,320147.80281982536,0.8152020073583057,-0.2947704908783517,0.26480646963023774,0.5265330007344392,Downregulated
Feature0660,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,276213.39076464303,296056.720292885,1.0718405775813749,0.10009033953027731,0.6281196586288779,0.7784616783224064,Upregulated
Feature0659,NA,C19 H41 N O2,315.3138,NA,NA,Feature0659,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,161887.981112799,138771.635126498,0.8572077690548616,-0.22228316936411838,0.17636109411047043,0.4872332821127231,Downregulated
Feature0658,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,2253761.0802726434,2655871.1896785,1.178417363280234,0.23685059289792254,0.050230257974196,0.42423678559897127,Upregulated
Feature0657,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0657,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,2776131.6444706,3186505.070456417,1.1478220338733518,0.19889897411157031,0.08891897019632973,0.4407379248873613,Upregulated
Feature0656,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1418689.17020725,1461529.7799214567,1.0301973191970926,0.042920690964859856,0.840630860458322,0.9139416913122455,Upregulated
Feature0655,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,11841006.036068866,10568795.122406123,0.8925588831060922,-0.163980746403379,0.10244282338822885,0.4501055128430483,Downregulated
Feature0654,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,10959770.7660261,4210796.609921163,0.384204806817137,-1.380052526097704,7.055258699906102e-5,0.03958000130647323,Downregulated
Feature0653,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,16315144.058826333,13755269.571202466,0.8430982602179967,-0.2462273127495356,0.08242769263853954,0.4407379248873613,Downregulated
Feature0652,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,564502.90548383235,456412.95054806065,0.808521880249441,-0.3066412783928399,0.08087986887409421,0.4407379248873613,Downregulated
Feature0651,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,631610.8570609661,492796.86733258865,0.7802222869088863,-0.35804288561268877,0.7776207672728662,0.8777570431389898,Downregulated
Feature0650,NA,C19 H41 N O2,315.31381,NA,NA,Feature0650,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,235701.43935750634,205178.581422948,0.8705020299504322,-0.20008043274216664,0.05237041532437441,0.4299742594402713,Downregulated
Feature0649,NA,C12 H21 N O8,307.12685,NA,NA,Feature0649,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1756543.14796905,1865635.0242956267,1.0621060043146169,0.08692776262701311,0.3747530919062657,0.5884259320625093,Upregulated
Feature0648,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0648,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,125299.44149451566,110964.340898468,0.8855932602327273,-0.1752838522911817,0.2813255138938125,0.5395679104471525,Downregulated
Feature0647,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,2356997.5545914234,2701514.7414543834,1.146167816844715,0.19681829261536785,0.1054439319153769,0.45172120667857957,Upregulated
Feature0646,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0646,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,480277.7781182943,572154.8409386633,1.1912998414799432,0.2525365747242829,0.6722984809143879,0.8019811300775679,Upregulated
Feature0645,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,627133.013728074,654886.9382795283,1.0442552440134947,0.062474388406874665,0.9192048790503018,0.961497966459466,Upregulated
Feature0644,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0644,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,95107.92648220116,7867065.80494634,82.71724656323583,6.370116257865172,0.03478839388613412,0.3917457709388165,Upregulated
Feature0643,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,1900838.8188748537,3073054.621943923,1.6166834301936914,0.6930372060828893,0.255058885042933,0.5160466413580144,Upregulated
Feature0642,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,13320441.147434,10373676.533132987,0.7787787520183844,-0.36071457238011045,0.015471196439042097,0.3605734563057726,Downregulated
Feature0641,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,8239247.494070889,7787250.822711053,0.9451410251136283,-0.08139848401672266,0.3489980776257389,0.5724452615273762,Downregulated
Feature0640,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,407285.83229822735,354781.20897886035,0.8710865462147441,-0.19911203095193267,0.33498053961874563,0.5724452615273762,Downregulated
Feature0639,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0639,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,972542.9505848873,1343196.0643515133,1.3811174751137882,0.46583603759454234,0.009088128213465356,0.3605734563057726,Upregulated
Feature0638,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0638,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,1287220.00782245,1139105.64844205,0.884934697658281,-0.17635709713868705,0.16626533494422863,0.48555687878974874,Downregulated
Feature0637,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,2492630.46971396,3512259.1159270103,1.409057282498058,0.49473026281578714,0.012761933742217974,0.3605734563057726,Upregulated
Feature0636,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0636,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,261602.04981454267,227079.65399533234,0.8680346891636198,-0.20417539682092017,0.15904309245014794,0.47628186389725785,Downregulated
Feature0635,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,685195.7295454566,552581.2363468601,0.8064575018782297,-0.3103295856167732,0.5190150282989981,0.6974070200616478,Downregulated
Feature0634,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4282062.583251653,3991789.90734168,0.9322119492028652,-0.10127008925655798,0.41844984930350404,0.615243020119386,Downregulated
Feature0633,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,2985465.9688115167,3790002.96329729,1.269484563847181,0.3442428528062028,0.07535789554959711,0.4407379248873613,Upregulated
Feature0632,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,11968899.831275167,11504899.752869401,0.961232854736296,-0.057042134564542886,0.6185008051527325,0.7702085498128367,Downregulated
Feature0631,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0631,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,222695.428256991,185348.825648984,0.8322973987373061,-0.2648289667389241,0.1819550036145723,0.48745712214463777,Downregulated
Feature0630,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,4101202.31831195,2160255.1610380965,0.5267370379150802,-0.924845187630681,0.03536577593742244,0.3917457709388165,Downregulated
Feature0629,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,5099120.835370443,3754089.21457407,0.7362228383633395,-0.44178559063879974,0.016943459773541242,0.37275611501790734,Downregulated
Feature0628,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,756379.9560356986,1589978.3225193068,2.1020894456968726,1.071824058509333,0.017356985714337074,0.3745103456055038,Upregulated
Feature0627,NA,C15 H27 N O13,429.14831,NA,NA,Feature0627,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,22859496.1222334,15340922.761937227,0.6710962778841164,-0.5754083393978712,0.2881282537106025,0.5470049080597226,Downregulated
Feature0626,NA,C6 H2 O4,137.99529,NA,NA,Feature0626,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,20293903.71421413,18515629.8398131,0.9123739868167648,-0.13230278110168292,0.2651436233644903,0.5265330007344392,Downregulated
Feature0625,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0625,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,506757.299777995,507186.82113703195,1.0008475879069234,0.001222292942821476,0.9964139150540459,0.9973027767088666,Upregulated
Feature0624,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,470154.2939667743,555543.5744527477,1.18161969715416,0.24076578059734274,0.711455614836794,0.8271679655506106,Upregulated
Feature0623,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,1759409.6278514366,1440107.1238683402,0.8185172463941648,-0.2889152798675854,0.20396871209868075,0.48745712214463777,Downregulated
Feature0622,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0622,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,7720762.534879937,7820765.888793133,1.0129525229485317,0.01856655665448909,0.9408334217934089,0.9711270462301792,Upregulated
Feature0621,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0621,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,148196.67606052835,126766.89050934167,0.8553963144056345,-0.22533510371259297,0.18227870679695868,0.48745712214463777,Downregulated
Feature0620,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,2582370.538939927,2385466.75854223,0.9237507641027664,-0.11442444226801535,0.35794785929867845,0.5729208247262728,Downregulated
Feature0619,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0619,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,596761.9051453964,536559.8018199557,0.8991187225485298,-0.15341646844319445,0.012012234067289058,0.3605734563057726,Downregulated
Feature0618,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1284702.6850197096,1290923.832695037,1.0048424804804015,0.006969361661970011,0.9925926392113813,0.9953463452766674,Upregulated
Feature0617,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0617,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,429988.795650106,824327.106090031,1.9170897344981268,0.9389178677757808,0.016068335842503233,0.3605734563057726,Upregulated
Feature0616,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,2376542.60155168,2291977.38118491,0.9644167033607746,-0.05227145675584982,0.7041376698464632,0.8222626959969398,Downregulated
Feature0615,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,137347.144385441,123576.577352987,0.8997389636743427,-0.15242159393068666,0.2837103991847953,0.5419860986174846,Downregulated
Feature0614,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,963977.0982410656,802545.9434268817,0.8325363173993018,-0.2644148872211173,0.15460614700563136,0.47268226304818617,Downregulated
Feature0613,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,13526006.542495733,13212353.393672,0.9768111047530323,-0.03384849337340504,0.8089883890881897,0.8995886744865698,Downregulated
Feature0612,NA,C13 H27 N O11,373.15852,NA,NA,Feature0612,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,129028.61511265399,114402.77389923844,0.8866465303014697,-0.1735690192399043,0.6388587213567871,0.780256870266987,Downregulated
Feature0611,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,2496379.5547234467,2028877.8221490267,0.8127281039095793,-0.29915531177436816,0.06273380889930609,0.43620489220914954,Downregulated
Feature0610,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,141941.883061507,120238.23093015533,0.8470947992006918,-0.23940466289351767,0.14173179958654025,0.470482482651178,Downregulated
Feature0609,NA,C12 H21 N O8,307.12682,NA,NA,Feature0609,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,19387780.583761867,16406388.337382367,0.8462231283514448,-0.24088997796886627,0.2105274500530899,0.4885184509681622,Downregulated
Feature0608,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,152029.754437951,177668.189469802,1.168640902740621,0.22483168998719855,0.34099413617956453,0.5724452615273762,Upregulated
Feature0607,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,161417.547430742,413615.40659695567,2.5623943194553984,1.3574925049335504,0.04494181025619463,0.393943055526956,Upregulated
Feature0606,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,570090.045416222,515849.562823832,0.9048562888818922,-0.14423941626161235,0.38140223582897637,0.5935274737865623,Downregulated
Feature0605,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,413339.572754032,461128.6055127727,1.1156168823621897,0.1578416716014166,0.45396359094181393,0.6488498713843506,Upregulated
Feature0604,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,11234863.970136767,12175162.559531966,1.0836947017689393,0.1159583782045407,0.30284528247764136,0.5561250522748177,Upregulated
Feature0603,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,250404.13060833467,214354.31367064166,0.8560334573949991,-0.2242609105570153,0.17650674103546166,0.4872332821127231,Downregulated
Feature0602,NA,C12 H21 N O8,307.12679,NA,NA,Feature0602,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,4428933.261742136,5274805.378578126,1.1909877767052337,0.2521586066720226,0.13072353234780879,0.4627741841989286,Upregulated
Feature0601,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0601,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,741973.5517860977,1207211.7657847467,1.6270280293397463,0.7022391050000732,0.023708518426104573,0.39036770986176245,Upregulated
Feature0600,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,808611.2396173794,683712.8053578826,0.8455395768198863,-0.2420558110439442,0.1753130960568954,0.4872332821127231,Downregulated
Feature0599,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0599,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,4082825.7927610264,3332214.8376084734,0.8161540576912665,-0.29308659307161566,0.037876788302870314,0.3917457709388165,Downregulated
Feature0598,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1384419.2568180633,14600066.087941889,10.545985990904626,3.3986220802692486,0.0712571923534831,0.4407379248873613,Upregulated
Feature0597,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,160504.91391375865,165764.43056298333,1.0327685708865628,0.04651700246957361,0.8958618167008809,0.9497007697011406,Upregulated
Feature0596,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,21724474.112660233,17809362.801215135,0.8197833792826537,-0.2866853545725965,0.12317848883747408,0.4627741841989286,Downregulated
Feature0595,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,12976738.524931934,12092093.006104765,0.9318283621784074,-0.10186385228020858,0.6285973980036543,0.7784616783224064,Downregulated
Feature0594,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,464086.7833602863,459686.829820526,0.9905191147485352,-0.013743278796493863,0.9043552407219926,0.9518635835741798,Downregulated
Feature0593,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0593,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1218518.8952161965,1513131.20121949,1.2417790213675937,0.31240846410460354,0.14978028748918187,0.47268226304818617,Upregulated
Feature0592,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,7824511.79672976,6074135.463493033,0.776295776821719,-0.3653216558100214,0.18910928993886922,0.48745712214463777,Downregulated
Feature0591,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2858494.11564644,3707708.583114587,1.297084560300415,0.3752725356801309,0.5093146618827827,0.6871399222855217,Upregulated
Feature0590,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0590,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,437246.5216561567,364384.69528839167,0.8333621360970772,-0.26298454237021157,0.1423477806930289,0.47069768053866784,Downregulated
Feature0589,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,297116.51628305967,163893.6587777829,0.5516140968132623,-0.8582687686686874,0.062227253469265095,0.43620489220914954,Downregulated
Feature0588,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3979271.9920379366,3333008.9260493033,0.8375926382308797,-0.2556793326980058,0.23865067910268617,0.5073945532162878,Downregulated
Feature0587,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,506877.8009376317,409119.95286056463,0.8071372470914433,-0.3091140820254193,0.0653495140271739,0.43620489220914954,Downregulated
Feature0586,NA,C17 H29 N O14,471.15895,NA,NA,Feature0586,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,12708161.388135932,10609867.038338387,0.8348860794484033,-0.26034874020764864,0.38279842969950334,0.5948751220537989,Downregulated
Feature0585,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,8338021.43167465,6280783.42080201,0.7532702418996476,-0.4087605584040117,0.38519632351458416,0.597451319543438,Downregulated
Feature0584,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,849099.432889472,736274.3812944316,0.8671238641496927,-0.20569000521090677,0.3128072508011539,0.5612627169376326,Downregulated
Feature0583,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,650631.5708935,281899.843855311,0.43327108069499803,-1.2066581498314006,0.05919290705718129,0.43620489220914954,Downregulated
Feature0582,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,1712319.3413997567,1677666.7464434132,0.9797627731472003,-0.029495618551583773,0.9029669805992567,0.9518635835741798,Downregulated
Feature0581,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,1437939.7644385167,1049969.4948085023,0.7301901795715983,-0.453655828988609,0.3490427204542596,0.5724452615273762,Downregulated
Feature0580,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,7863352.07785838,5957315.562604544,0.7576050905032152,-0.40048207028609195,0.0319794685105419,0.3917457709388165,Downregulated
Feature0579,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,14618529.128715834,15099257.659090767,1.0328848768670316,0.046679463468641755,0.8326922347517798,0.908833353493674,Upregulated
Feature0578,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,681824.9734964999,626612.024505015,0.9190218147799064,-0.12182898777864505,0.5026501272764166,0.6852654226052726,Downregulated
Feature0577,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0577,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,826315.4622349043,699382.2660894106,0.846386517078862,-0.24061144935696732,0.3855211723257122,0.597451319543438,Downregulated
Feature0576,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,434328.69535566436,373854.847397207,0.8607647880393066,-0.21630903321043427,0.17924951343212206,0.48745712214463777,Downregulated
Feature0575,NA,C6 H11 N O7,209.05351,NA,NA,Feature0575,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,4010100.4350957433,3552885.2863518097,0.885984115324778,-0.1746472617364175,0.12933878030270324,0.4627741841989286,Downregulated
Feature0574,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0574,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,7661675.098368287,15041823.486461401,1.9632552011589306,0.9732477191698058,0.0013239926844114249,0.18568997398870232,Upregulated
Feature0573,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0573,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,580918.213911478,603019.5235701853,1.0380454754721724,0.053869647743075816,0.9077688603516996,0.9532692248087129,Upregulated
Feature0572,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,454736.37264359463,380369.28159844066,0.8364610892838341,-0.2576296647288285,0.2992990238085932,0.555822019398608,Downregulated
Feature0571,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,10090323.568343783,9407062.669117266,0.9322855313213047,-0.10115621776192237,0.7140512600642086,0.8276503241653328,Downregulated
Feature0570,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1860134.18538544,1741040.5513112834,0.9359757833548555,-0.09545689166609832,0.6591679841502416,0.7927337308310282,Downregulated
Feature0569,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1452640.39965262,1725097.0169269068,1.1875595758863935,0.2479998904371962,0.3238493605252856,0.5692978351524217,Upregulated
Feature0568,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,1682045.8140896866,2282734.219314053,1.3571177432818353,0.4405458941390412,0.1529968990404469,0.47268226304818617,Upregulated
Feature0567,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,158617.98479406367,132553.16323245366,0.8356754967259835,-0.2589852604143012,2.3499789448624107e-4,0.07219221508475557,Downregulated
Feature0566,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0566,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,931862.8849649907,1214576.4293725644,1.3033853466738243,0.38226368064095434,0.21976570194297684,0.49414252020044086,Upregulated
Feature0565,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0565,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,207118.31111234767,181986.59428461766,0.8786600919408919,-0.18662292554942309,0.02195379588024645,0.39036770986176245,Downregulated
Feature0564,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,148491.14606548302,211446.30471505437,1.423965740164796,0.5099144362699478,0.46111844988638,0.6519708164262784,Upregulated
Feature0563,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,347420.92715872434,299368.87833791436,0.8616892505187038,-0.2147604083615593,0.5598897757128553,0.7237768804931469,Downregulated
Feature0562,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,4340545.543484273,4494979.52944551,1.0355793953580472,0.05043816572485084,0.6877501691218066,0.8103781128808827,Upregulated
Feature0561,NA,C11 H23 N O11,345.1272,NA,NA,Feature0561,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,5183657.99113296,3948532.3980637467,0.7617270284455516,-0.3926540069626684,0.20217575802949925,0.48745712214463777,Downregulated
Feature0560,NA,C10 H15 N O5,229.09493,NA,NA,Feature0560,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,4638961.618932056,3454409.4159777435,0.7446514327430434,-0.42536282895213,0.005903278057193728,0.3486041042195454,Downregulated
Feature0559,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0559,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,15098501.209681766,13317425.443839034,0.8820362537242681,-0.18109013979242108,0.19332814219996228,0.48745712214463777,Downregulated
Feature0558,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1242863.2405179634,938757.790474354,0.7553186544346799,-0.4048426766943305,0.14093764805444361,0.470482482651178,Downregulated
Feature0557,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,293936.66363510664,252888.12225160832,0.8603490259573198,-0.21700604453026842,0.18937581601564116,0.48745712214463777,Downregulated
Feature0556,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,129942.51568275166,1612318.13694798,12.407933835022682,3.633190993261563,0.03319393008240889,0.3917457709388165,Upregulated
Feature0555,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8879635.999791592,8004308.432280477,0.9014230349609309,-0.1497237777392515,0.17606653248086296,0.4872332821127231,Downregulated
Feature0554,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,6590713.691472883,5156442.567532403,0.7823799984216958,-0.35405860668653183,0.03960855852119203,0.3917457709388165,Downregulated
Feature0553,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,273003.275606527,190782.8892842293,0.6988300373333252,-0.5169864749261883,0.556513724882232,0.7237768804931469,Downregulated
Feature0552,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,6853049.22681754,6803953.728889257,0.9928359630431135,-0.010372720389818041,0.8632198339645356,0.9294939095088377,Downregulated
Feature0551,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,3200354.935731467,3077693.252675377,0.9616724752349837,-0.056382467846172034,0.6363285027154413,0.780256870266987,Downregulated
Feature0550,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,261829.51008365865,227403.32451111067,0.868516785745242,-0.20337436284587995,0.14042145135457493,0.470482482651178,Downregulated
Feature0549,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,737347.1058619787,603270.5922916166,0.8181636402930977,-0.28953867051205934,0.406233193680861,0.6115057027381818,Downregulated
Feature0548,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0548,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,1500250.84885299,1238021.1371686268,0.8252094228876126,-0.27716779974680655,0.08057684204670156,0.4407379248873613,Downregulated
Feature0547,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0547,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,8179855.42166314,7926825.843103713,0.9690667419512923,-0.04533206395673764,0.3087472593280198,0.559635581528333,Downregulated
Feature0546,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,5559791.810164317,4587406.7232856,0.8251040470434488,-0.27735203772435585,0.3166718740347821,0.5621927890301036,Downregulated
Feature0545,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0545,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,399656.49128394265,350114.8829097123,0.8760395253056639,-0.19093213182339594,0.19695796682528263,0.48745712214463777,Downregulated
Feature0544,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,205656.44421094333,184833.53057203535,0.898749034007659,-0.15400977997031845,0.24631450939561259,0.5073945532162878,Downregulated
Feature0543,NA,C11 H19 N O5,245.12631,NA,NA,Feature0543,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,263641.8356860467,258309.87271804432,0.9797757326559058,-0.029476535875855088,0.9476128702205453,0.9745386254697084,Downregulated
Feature0542,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,7156866.246208927,9514548.037525212,1.329429349411857,0.4108071093042759,0.13327068892315672,0.46582465100243564,Upregulated
Feature0541,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0541,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,431272.34686770366,328002.02370770863,0.7605449922536442,-0.39489449758689993,0.18860353702285046,0.48745712214463777,Downregulated
Feature0540,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0540,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,1138794.3831268232,1324937.98982097,1.1634567306022765,0.2184175573644048,0.13958304376182104,0.470482482651178,Upregulated
Feature0539,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,3807886.82367337,4505302.884303987,1.183150417258945,0.24263349923869165,0.08914437786518549,0.4407379248873613,Upregulated
Feature0538,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,434133.65973693336,345310.31992315,0.7954009374264909,-0.330245832442814,0.5025329312007715,0.6852654226052726,Downregulated
Feature0537,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,1408019.8711941766,1042000.8621584501,0.74004698617975,-0.43431122336664924,0.29906589027699376,0.555822019398608,Downregulated
Feature0536,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0536,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5850535.03182037,6683290.106444703,1.1423382767721375,0.19198993437422962,0.33870823779592335,0.5724452615273762,Upregulated
Feature0535,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,2217669.756245587,2094382.1224252668,0.9444066757581433,-0.08251985525946877,0.2948692999003941,0.5514055908137371,Downregulated
Feature0534,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0534,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,4387359.5967087,3223190.15294915,0.7346537437613083,-0.44486365427413205,0.17531442528969546,0.4872332821127231,Downregulated
Feature0533,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,380891.5458207697,385027.44606373267,1.0108584721513068,0.015581023137791033,0.973533511680267,0.9837336522122435,Upregulated
Feature0532,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0532,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,4751854.388422407,4802846.090832043,1.0107309059246163,0.015398949404251131,0.8972217610367281,0.9497007697011406,Upregulated
Feature0531,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,14624796.4883597,12701138.1174212,0.8684659733576741,-0.2034587698777826,0.12270686226689327,0.4627741841989286,Downregulated
Feature0530,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,252659.59997547267,244882.96677850676,0.9692209075066974,-0.04510256872904003,0.9587377195088209,0.9793905680146824,Downregulated
Feature0529,NA,C12 H19 N O9,321.10608,NA,NA,Feature0529,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,651709.2042680047,986178.6613053904,1.5132188633319357,0.5976206658151636,0.24275336899915226,0.5073945532162878,Upregulated
Feature0528,NA,C6 H15 N O4,165.10013,NA,NA,Feature0528,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,243515.621447785,216390.36303690568,0.8886097809676019,-0.1703780736432108,0.02595157903377423,0.39036770986176245,Downregulated
Feature0527,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,5238877.480171593,3429446.1326555233,0.6546146852327602,-0.6112821275874308,0.060719625070726056,0.43620489220914954,Downregulated
Feature0526,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0526,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,2820514.791995853,2009450.1513280866,0.7124409193068473,-0.48915771434660843,0.04634176641360007,0.4030655962485215,Downregulated
Feature0525,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,4640039.74354251,3527935.2318362966,0.7603243564338179,-0.39531308739622667,0.0052482128150371996,0.3463820457924552,Downregulated
Feature0524,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0524,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,1549799.2832498634,962491.3726863146,0.6210425976375541,-0.6872358678381022,0.3026542611675605,0.5561250522748177,Downregulated
Feature0523,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0523,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,3199657.302704117,2817075.869665583,0.8804304971300508,-0.18371897544588045,0.46231061886625685,0.6519708164262784,Downregulated
Feature0522,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0522,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,97768.86471196507,84866.25084071867,0.8680294190869605,-0.20418415584476654,0.1261475824476232,0.4627741841989286,Downregulated
Feature0521,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,587105.2826041013,407461.3561037757,0.6940175266290974,-0.5269559979893013,0.21870201561093866,0.49414252020044086,Downregulated
Feature0520,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1197954.561648587,771261.710274652,0.6438154959844772,-0.6352807934509047,0.14389421071725764,0.47069768053866784,Downregulated
Feature0519,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,359343.31825490366,250331.07502326232,0.6966348400158301,-0.5215254682717202,0.12545401756403887,0.4627741841989286,Downregulated
Feature0518,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,874063.3739538777,565848.8334520317,0.6473773530772498,-0.6273211976359548,0.46370501444382506,0.6526910819559771,Downregulated
Feature0517,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,633815.057775602,760390.3617725713,1.199703844905784,0.2626783106524358,0.7124451751591614,0.8271679655506106,Upregulated
Feature0516,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0516,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,1673434.33959367,1869897.53098731,1.1174011951023686,0.16014726842170696,0.6167417090206074,0.7688713305790239,Upregulated
Feature0515,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0515,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1499484.5188012568,1593528.1891615135,1.0627173333109425,0.08775791289886704,0.40305131360856106,0.6115057027381818,Upregulated
Feature0514,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0514,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,1646060.1409647767,1550172.91736042,0.9417474360638148,-0.08658789449070164,0.5310171956052403,0.7072097828449871,Downregulated
Feature0513,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,3036882.85041127,2548284.8113640267,0.8391119897887814,-0.2530647260209898,0.19284896469246657,0.48745712214463777,Downregulated
Feature0512,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1220935.6593759235,1833914.40504952,1.502056550618661,0.5869391296040409,0.03888471947908744,0.3917457709388165,Upregulated
Feature0511,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,274063.365890103,355398.963858522,1.2967766147958422,0.3749299796029868,0.5061942007549527,0.6871399222855217,Upregulated
Feature0510,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,2141869.27346182,1899053.5608572867,0.886633738289695,-0.17358983374089149,0.20643358355056274,0.48745712214463777,Downregulated
Feature0509,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,1896537.59615744,4578253.022640583,2.4140059400438703,1.2714292260768991,0.07651303016668375,0.4407379248873613,Upregulated
Feature0508,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1922400.47988357,1305034.4359668153,0.6788566948578033,-0.5588210379994117,0.41842278752060985,0.615243020119386,Downregulated
Feature0507,NA,C33 H47 N O8,585.33043,NA,NA,Feature0507,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,177154.91163503833,145387.63054302466,0.8206807770734671,-0.2851069336523476,0.08085998002898533,0.4407379248873613,Downregulated
Feature0506,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,890616.5051373136,728984.96945298,0.8185172464781421,-0.2889152797195695,0.20396871244367346,0.48745712214463777,Downregulated
Feature0505,NA,C29 H28 O9,520.17351,NA,NA,Feature0505,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,579913.2855504804,587574.0775565039,1.0132102371111427,0.01893355870753227,0.8964381744785919,0.9497007697011406,Upregulated
Feature0504,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,4325689.7946088435,3767867.2594931633,0.8710442584646498,-0.1991820696966693,0.16643842358179747,0.48555687878974874,Downregulated
Feature0503,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,8622675.88225524,5117959.577190977,0.5935465564376968,-0.7525668988744099,0.3254558115827843,0.5692978351524217,Downregulated
Feature0502,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,304995.649331857,247035.305147314,0.809963373866104,-0.3040714233548253,0.043009667036502296,0.3917457709388165,Downregulated
Feature0501,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,269067.84935073636,197535.96070613133,0.7341492533678318,-0.44585470047827014,0.21808475419567117,0.49414252020044086,Downregulated
Feature0500,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3505998.8527131532,2723725.4957837933,0.7768757521628994,-0.3642442119194599,0.2066365763870667,0.48745712214463777,Downregulated
Feature0499,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0499,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,111997.46991837966,95956.32701853577,0.8567722743064269,-0.22301630056929658,0.076255363358269,0.4407379248873613,Downregulated
Feature0498,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0498,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,214511.67808468832,182060.03705933967,0.848718534510103,-0.23664191118267605,0.1953538908832599,0.48745712214463777,Downregulated
Feature0497,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,11107680.287953367,9641276.855698217,0.867982927646422,-0.20426142830293872,0.10234933137224984,0.4501055128430483,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,807879.3390159577,412207.31033709465,0.510233756985525,-0.9707697443112455,0.18277155397527992,0.48745712214463777,Downregulated
Feature0495,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,162922.17480417967,203286.07222849334,1.2477495618557024,0.3193283972405542,0.4513849021833567,0.6476392074804683,Upregulated
Feature0494,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,824297.7788341991,568220.67111696,0.6893390783129273,-0.536714291539731,0.37604406891224124,0.5884538986325448,Downregulated
Feature0493,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,432395.7338301017,1079558.1624473832,2.4966901335607687,1.3200167782082526,0.009679731907181405,0.3605734563057726,Upregulated
Feature0492,NA,C10 H23 N O6,253.1525,NA,NA,Feature0492,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1073007.97639857,940084.213010319,0.8761204331076881,-0.1907988959458472,0.2716974772667186,0.5329450515616403,Downregulated
Feature0491,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,191544.11932075533,208215.80636876234,1.0870383654018059,0.12040285903879627,0.7535200813063965,0.860070733698654,Upregulated
Feature0490,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,811846.0594055464,735650.9636599887,0.906145882137619,-0.1421847637172483,0.5095369120691212,0.6871399222855217,Downregulated
Feature0489,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0489,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,1892146.9152529798,1728483.4486085,0.9135038271472709,-0.13051732181476008,0.741933990168383,0.8509437710669626,Downregulated
Feature0488,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0488,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3250819.4352519433,3493998.64223423,1.0748055103723224,0.1040756229713872,0.05880316817382921,0.43620489220914954,Upregulated
Feature0487,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,526409.356172381,550238.2042706517,1.0452667640095432,0.06387118153989764,0.6776558205952725,0.8028826089840505,Upregulated
Feature0486,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,3926939.02274819,3257517.621419533,0.8295309915812812,-0.2696322130848903,0.005750542030953792,0.3486041042195454,Downregulated
Feature0485,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,264350.279051157,247184.19922463867,0.9350631295411027,-0.09686432496585479,0.10910064320704674,0.45172120667857957,Downregulated
Feature0484,NA,C18 H29 N O12,451.16881,NA,NA,Feature0484,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,196789.73694820667,283054.9608901513,1.4383624129984427,0.524427226236646,0.4921079442182509,0.6766864944350365,Upregulated
Feature0483,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,4695773.30681212,4553527.824864887,0.9697077621398634,-0.04437806267509444,0.8344486264137112,0.9098652661187404,Downregulated
Feature0482,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0482,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2429016.5699498,2855722.7861833433,1.175670360388839,0.23348360771067728,0.10325213680213616,0.4501055128430483,Upregulated
Feature0481,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,6434610.682019849,4043152.4603225095,0.6283445355319225,-0.6703722564649554,0.011752067051984574,0.3605734563057726,Downregulated
Feature0480,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,322915.0643693377,244121.591814721,0.7559931968225063,-0.4035548431851869,0.3018123411186702,0.5561250522748177,Downregulated
Feature0479,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,10070755.182066014,10491101.155337166,1.0417392703597546,0.05899424073785527,0.36239225035317113,0.578384217491121,Upregulated
Feature0478,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0478,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,106134.031152414,116237.22577333813,1.0951927907686405,0.1311848550351824,0.6768016619705715,0.8028826089840505,Upregulated
Feature0477,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,3250112.1076329034,2868335.7198111233,0.8825343941443815,-0.18027559067394502,0.2401115998016777,0.5073945532162878,Downregulated
Feature0476,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,276637.58336454234,317103.2310472403,1.1462767538327354,0.19695540637987508,0.679553562699605,0.8042817482583933,Upregulated
Feature0475,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2291085.750308477,10616897.00269377,4.634002459866152,2.212258810028319,0.0257276115658242,0.39036770986176245,Upregulated
Feature0474,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0474,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,1040932.2604806367,1270870.36350895,1.2208963174242888,0.2879406870663972,0.013497567502247882,0.3605734563057726,Upregulated
Feature0473,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,4538738.19480446,4448230.196609483,0.9800587753004608,-0.029059822912754465,0.8524253187375225,0.9231864938450773,Downregulated
Feature0472,NA,C19 H35 P S,326.21985,NA,NA,Feature0472,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,2553375.856505474,789886.8478558267,0.30935001043554095,-1.6926880122682744,0.40867082070065697,0.6115057027381818,Downregulated
Feature0471,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,158393.62594656966,130082.80455683266,0.8212628745598198,-0.2840840128094527,0.14463567624630544,0.47109171189328686,Downregulated
Feature0470,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,8323443.928790573,8763164.228854276,1.0528291298440449,0.07427131145417751,0.651584031031918,0.7882293181406611,Upregulated
Feature0469,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,1687922.5818621467,1524844.4166150533,0.9033852814107253,-0.1465866863241736,0.20209745833815088,0.48745712214463777,Downregulated
Feature0468,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,264855.38003611437,236763.813472335,0.8939362056381526,-0.16175621548480038,0.23981629953616598,0.5073945532162878,Downregulated
Feature0467,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,10255007.402919844,8589860.38704014,0.8376259567198755,-0.2556219450603622,0.031758070168378186,0.3917457709388165,Downregulated
Feature0466,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,11224732.234495733,11248001.1717537,1.0020730059988832,0.0029876198661668105,0.9661745547822386,0.9813025074337496,Upregulated
Feature0465,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,6746691.815821454,6471259.43764071,0.9591751949400095,-0.060133744933977634,0.674750612115173,0.8019811300775679,Downregulated
Feature0464,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0464,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,2954882.82962885,3384925.8286906765,1.1455363964857592,0.19602329731158127,0.2227123327253432,0.49581507401192965,Upregulated
Feature0463,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3810151.17316255,3831552.7689675866,1.0056169938756714,0.008080935114693787,0.9690580911199596,0.9813025074337496,Upregulated
Feature0462,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0462,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,269896.05519342964,239785.676656769,0.8884371299347777,-0.1706584070301522,0.3463302008280678,0.5724452615273762,Downregulated
Feature0461,NA,C29 H28 O9,520.17353,NA,NA,Feature0461,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,188697.10278082266,164071.84236190334,0.8694984710627894,-0.20174460420664522,0.14375954954223744,0.47069768053866784,Downregulated
Feature0460,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3439013.779260067,3129755.082492363,0.9100734348222812,-0.1359451322359759,0.4594404689127435,0.6519708164262784,Downregulated
Feature0459,NA,C14 H29 N O2,243.2198,NA,NA,Feature0459,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,220287.41695922366,182225.191903842,0.8272156186641056,-0.2736646694418085,0.07935228629503877,0.4407379248873613,Downregulated
Feature0458,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0458,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,348999.98628101934,295851.07972196897,0.8477108634719138,-0.23835581944475817,0.19611993090895838,0.48745712214463777,Downregulated
Feature0457,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,192024.845314962,170341.95932434566,0.8870829139060014,-0.17285913817327211,0.2078252729269205,0.48745712214463777,Downregulated
Feature0456,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,979277.5780668797,1067769.6182074067,1.0903646137954193,0.1248106474371093,0.5971689244625566,0.754531005908771,Upregulated
Feature0455,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0455,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,3133141.1425337167,3106038.5388701535,0.9913497022857879,-0.012534031664822455,0.5786164188231353,0.7360630634008593,Downregulated
Feature0454,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,7022029.36626946,8222378.5336067,1.170940493798439,0.22766776116513002,0.4363062196514876,0.6308448175888777,Upregulated
Feature0453,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,5514830.455508783,5572461.979140843,1.0104502802211248,0.014998334836740002,0.9593139342675009,0.9793905680146824,Upregulated
Feature0452,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,261419.392957726,199359.459941337,0.7626039433638166,-0.39099410374372007,0.0360474698821512,0.3917457709388165,Downregulated
Feature0451,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,617313.2235678076,993509.9830966094,1.6094098508931085,0.6865317682962404,0.6220501327486634,0.7737696773215081,Upregulated
Feature0450,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1488955.0949546234,1173623.07367642,0.7882192536586784,-0.34333110458614213,0.19860881442616338,0.48745712214463777,Downregulated
Feature0449,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,3264098.998077113,2162061.21707415,0.6623761161496096,-0.5942774415756867,0.11891987817382912,0.4627741841989286,Downregulated
Feature0448,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,1837066.1726040954,1114218.5594031783,0.6065206447211102,-0.7213713423200324,0.4955348800385338,0.6795768574629762,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2007048.2567404234,2379707.6082579936,1.185675332053447,0.24570901750614627,0.06382143046580584,0.43620489220914954,Upregulated
Feature0446,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0446,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,126615.97084090467,109284.12769642,0.8631148738237575,-0.212375511303721,0.10057982691833162,0.4478197055649527,Downregulated
Feature0445,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0445,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,4800666.730799323,4365713.37650945,0.9093973027747644,-0.13701736975723228,0.4927387397089348,0.6766864944350365,Downregulated
Feature0444,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,140519.23507305732,120260.48393833333,0.8558293380675516,-0.22460495909131883,0.12715959923281261,0.4627741841989286,Downregulated
Feature0443,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0443,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,3200582.2908770265,3386200.830649203,1.0579952405227218,0.08133313738604908,0.42394219496278873,0.6193530504534491,Upregulated
Feature0442,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,235900.69321927067,3680168.1202433202,15.60049726866461,3.9635201108724862,0.0659950088529874,0.43620489220914954,Upregulated
Feature0441,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,4508895.544340527,4967023.288836733,1.1016053133169694,0.1396074230800283,0.042278493527488005,0.3917457709388165,Upregulated
Feature0440,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,209111.371480159,199415.188415887,0.9536314883516892,-0.06849622135782565,0.8838870485651704,0.9427158883012662,Downregulated
Feature0439,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1142328.3371850946,1205962.02861963,1.0557052551032222,0.07820710140520998,0.8243894039665065,0.9032860461429886,Upregulated
Feature0438,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,1372998.6528810367,1377989.5700166933,1.0036350488219226,0.005234758361375392,0.9541535184448688,0.9767885471671011,Upregulated
Feature0437,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,79800.74265864736,58905.67214875884,0.7381594479732039,-0.4379956119976104,0.34240023373587375,0.5724452615273762,Downregulated
Feature0436,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,507076.7913317947,614059.21125697135,1.2109787348858865,0.27617353113955767,0.014931911662643611,0.3605734563057726,Upregulated
Feature0435,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,533471.7721974626,409560.07920910435,0.7677258677100298,-0.3813368358884217,0.2544785083712728,0.5160466413580144,Downregulated
Feature0434,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0434,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,460312.6044680697,403392.54943802033,0.876344782920239,-0.19042950959706315,0.08592596810331665,0.4407379248873613,Downregulated
Feature0433,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0433,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,3085626.28081366,2712967.6736852066,0.8792275625063105,-0.1856914814984374,0.14309896143253834,0.47069768053866784,Downregulated
Feature0432,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0432,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6973409.488223823,5856252.368959623,0.8397975737477096,-0.25188647478683496,0.22059967371513056,0.49502566781675306,Downregulated
Feature0431,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0431,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,158385.31533642934,145942.45036923233,0.9214392764836382,-0.11803900054791276,0.35756744379192884,0.5729208247262728,Downregulated
Feature0430,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,254658.50060918034,374315.902833189,1.4698739760807933,0.5556924667097828,0.5034754722769651,0.6855576212314985,Upregulated
Feature0429,NA,C7 H15 N O6,209.08992,NA,NA,Feature0429,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2304689.566822233,1560365.5522827867,0.6770393612855461,-0.5626883841583983,0.042202073516871566,0.3917457709388165,Downregulated
Feature0428,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0428,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,148065.40382332765,124974.878979116,0.8440518564906399,-0.2445964575619285,0.0030620776914481924,0.24540365498606226,Downregulated
Feature0427,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2332937.359929207,1996135.2743148233,0.8556317493134047,-0.22493807834142795,0.5384723834337833,0.7133010793538429,Downregulated
Feature0426,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,1851766.0952052134,1453957.36791505,0.7851733389437189,-0.3489169088722558,0.08954265360182702,0.4407379248873613,Downregulated
Feature0425,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0425,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,126853.52542065067,107442.18149877567,0.846978285723583,-0.2396031117295005,0.10767099744970154,0.45172120667857957,Downregulated
Feature0424,NA,C16 H25 N O9,375.15307,NA,NA,Feature0424,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,11692639.948862532,10912830.188965026,0.9333076393946975,-0.09957539036672926,0.283853817953357,0.5419860986174846,Downregulated
Feature0423,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,3024449.349929807,2809874.8784862035,0.9290533757992729,-0.10616661045507052,0.39945270384969506,0.609776780570555,Downregulated
Feature0422,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,963867.8137974871,707832.0230422803,0.7343662822950109,-0.4454282745377247,0.2331625432129651,0.5030930259325901,Downregulated
Feature0421,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0421,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,126176.394545247,149642.60872595166,1.1859794319316173,0.2460789898944026,0.14146519652048584,0.470482482651178,Upregulated
Feature0420,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0420,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3595436.22652128,3678406.944807383,1.02307667639161,0.03291427460864705,0.8123719978563952,0.8996655060370997,Upregulated
Feature0419,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,765556.108651868,587003.7678493113,0.7667677930008495,-0.38313835497804954,0.7989486334854802,0.8928721304419024,Downregulated
Feature0418,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0418,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,224709.67045760565,185262.05520479367,0.8244507449435547,-0.2784947893972034,0.15045085660228538,0.47268226304818617,Downregulated
Feature0417,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0417,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2529752.1953672133,2320503.6283078166,0.9172849548494916,-0.12455811778786387,0.4092915418497881,0.6115057027381818,Downregulated
Feature0416,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,6327513.155586217,4784089.31787717,0.7560773403771682,-0.40339427727748317,0.27470607163349464,0.5341771444935546,Downregulated
Feature0415,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4951962.829012783,4974236.125333673,1.004497872276099,0.006474508162821318,0.9688677266438144,0.9813025074337496,Upregulated
Feature0414,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,1015348.9577595657,856808.3633050846,0.8438560524016183,-0.24493117438859432,0.5481076786201424,0.7201133669927398,Downregulated
Feature0413,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0413,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,539291.90401751,6726270.14591055,12.472410759001786,3.640668441683597,0.19537436754955032,0.48745712214463777,Upregulated
Feature0412,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0412,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,420898.7280734897,406086.3545081757,0.9648077492818469,-0.051686599957000534,0.5979938989744367,0.7547234585481641,Downregulated
Feature0411,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,9767328.466134083,9077664.203013124,0.9293906961855325,-0.10564289229628637,0.4264875820588889,0.6222614656307847,Downregulated
Feature0410,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0410,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,1080349.593296936,1197527.239510838,1.1084627114601926,0.14856023895010323,0.6052452786556622,0.7595784956804019,Upregulated
Feature0409,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,3664012.77984243,3603242.229493357,0.9834142089559834,-0.024128894658425094,0.9215908898082575,0.9627793094644924,Downregulated
Feature0408,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0408,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,244586.40449310266,216764.583705754,0.8862495205119496,-0.17421515307706426,0.38839035978890946,0.6002396469464965,Downregulated
Feature0407,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0407,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,429815.209677379,376876.51705635636,0.8768338313091372,-0.18962463130572202,0.3004185904301632,0.5561250522748177,Downregulated
Feature0406,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,380556.81582977634,332395.596517657,0.8734453902576745,-0.195210589418251,0.19392353474129836,0.48745712214463777,Downregulated
Feature0405,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0405,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,516007.7102550327,696863.8083736574,1.350491077021384,0.4334841076887705,0.05556174328129356,0.43364536838278145,Upregulated
Feature0404,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1104758.780075341,1025906.6135191813,0.9286249921898948,-0.1068319860447878,0.8894292109799207,0.9468117407205606,Downregulated
Feature0403,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,4244168.4827557,3798751.4966866667,0.8950520018517671,-0.15995659057277598,0.1723163482080213,0.4872332821127231,Downregulated
Feature0402,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,837772.3427169253,582909.7884882981,0.6957854285305015,-0.5232856292191692,0.559303852462984,0.7237768804931469,Downregulated
Feature0401,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0401,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,937737.5232626196,1596258.832796444,1.7022448107255712,0.7674385351563449,0.201263453199409,0.48745712214463777,Upregulated
Feature0400,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0400,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,5078054.304836503,5024901.599708743,0.9895328600410721,-0.015180478335997855,0.936935767629528,0.9698394378801211,Downregulated
Feature0399,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,2353372.8107762765,2010455.2318756334,0.8542867592714605,-0.22720767289110969,0.6362440459776982,0.780256870266987,Downregulated
Feature0398,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,6570913.9483081,10192356.282944543,1.5511322113066028,0.6333216602406917,0.013478801002615046,0.3605734563057726,Upregulated
Feature0397,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0397,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4451229.676574416,4034300.7664978104,0.9063339929928157,-0.14188529931752966,0.4575075307955461,0.6514256974017801,Downregulated
Feature0396,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,1618018.04233594,1458198.63444653,0.9012252003947507,-0.15004043957387073,0.4117413546175999,0.611898054554379,Downregulated
Feature0395,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0395,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,134991.054718968,184400.73867204267,1.3660219120143817,0.4499806257223959,0.13420962396389016,0.46620185166403955,Upregulated
Feature0394,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0394,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,103149.7102028694,87015.32339892977,0.8435828198430478,-0.2453983809549332,0.09544619302450136,0.4438331226509661,Downregulated
Feature0393,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0393,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,6800948.55193842,6345064.802464813,0.9329676226790937,-0.10010107963113435,0.5575546441051045,0.7237768804931469,Downregulated
Feature0392,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3342813.9925879533,3088058.449959797,0.9237900932588449,-0.11436302010436543,0.41174958216448854,0.611898054554379,Downregulated
Feature0391,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0391,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4410831.715151947,4710101.16531891,1.0678487572171302,0.09470732805162209,0.17067373226170704,0.48603027309044494,Upregulated
Feature0390,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,169282.92496769968,152652.03456427832,0.9017568345620526,-0.1491896424121782,0.30619362202871103,0.5595264558895989,Downregulated
Feature0389,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,10296509.271038467,8138528.350033083,0.7904162600935785,-0.3393154691754487,0.12425871184935978,0.4627741841989286,Downregulated
Feature0388,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0388,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,2894301.3566563632,2612547.83729527,0.9026523210124227,-0.14775769006012643,0.39758930613346716,0.6085882694157574,Downregulated
Feature0387,NA,C10 H21 N O10,315.11663,NA,NA,Feature0387,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4386693.354766868,6484096.527976443,1.4781285135717088,0.563771707801009,0.6736987529219999,0.8019811300775679,Upregulated
Feature0386,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0386,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,9548556.452670943,7576061.252784637,0.793424774764299,-0.33383464841052485,0.26221816806685555,0.5253728295910928,Downregulated
Feature0385,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0385,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,2536657.47619204,740337.0477728997,0.2918553469364233,-1.776674595527929,0.009960144524725132,0.3605734563057726,Downregulated
Feature0384,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,3234128.37277317,3258255.20619923,1.0074600728991385,0.010722663793607288,0.9257866319243067,0.9644685246230938,Upregulated
Feature0383,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,8014379.325274207,5153226.61531791,0.6429975929722538,-0.6371147579772074,0.003938245350916737,0.2945807522485719,Downregulated
Feature0382,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,596546.1838381013,473941.67044030764,0.7944760745782128,-0.3319243210116101,0.05565502054110564,0.43364536838278145,Downregulated
Feature0381,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,2099241.35606723,2136052.83660724,1.0175356113453164,0.025079286297175516,0.8920081311487943,0.9486569887667747,Upregulated
Feature0380,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,4077665.0241561565,3393391.3889796366,0.8321898363100276,-0.26501542630120756,0.2876226452663657,0.5469705220150209,Downregulated
Feature0379,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,4759575.34893523,5273996.053070944,1.1080812186849391,0.14806363003300266,0.039289932391014984,0.3917457709388165,Upregulated
Feature0378,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,1862766.92806426,2673842.12271514,1.4354142122835136,0.5214671102654003,0.19254319143567053,0.48745712214463777,Upregulated
Feature0377,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,247797.67476794682,215261.67389954944,0.8686993294070813,-0.20307117105027847,0.7889155143732298,0.885163207126764,Downregulated
Feature0376,NA,C13 H17 N O5,267.11069,NA,NA,Feature0376,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,2362814.0796642136,2191580.5240591364,0.9275298225625049,-0.10853442590719052,0.7847211236763414,0.8831064200249299,Downregulated
Feature0375,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0375,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,293722.66743559163,247245.04016201833,0.8417635667027127,-0.2485130267322752,0.3237452792733367,0.5692978351524217,Downregulated
Feature0374,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,1899874.1762777732,1805082.7143185968,0.950106452762629,-0.07383892852936134,0.35356913211984997,0.5724452615273762,Downregulated
Feature0373,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,148707.76979030934,122537.77675876266,0.8240173121522257,-0.2792534469281482,0.1543219534301668,0.47268226304818617,Downregulated
Feature0372,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0372,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,377223.48900708335,189189.64441562866,0.5015319828402206,-0.9955863900345114,0.14823407872463396,0.47268226304818617,Downregulated
Feature0371,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1164514.83134725,1165985.3684396667,1.0012627894920973,0.001820670817736763,0.9922008170455491,0.9953463452766674,Upregulated
Feature0370,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,7576554.61467097,6349380.96256172,0.8380301186329477,-0.2549259998630283,0.22347954668420417,0.49581507401192965,Downregulated
Feature0369,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,1991175.5400680634,1728649.18880039,0.8681550943224727,-0.2039752943580382,0.16882323803311194,0.48569146941833746,Downregulated
Feature0368,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1906761.2443236134,1607337.7351404633,0.8429674873692093,-0.24645110632469927,0.2010414779774006,0.48745712214463777,Downregulated
Feature0367,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0367,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,174044.02037155034,146726.14436569135,0.8430404219142915,-0.24632628804124307,0.05052281048143436,0.42423678559897127,Downregulated
Feature0366,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,193481.74220832955,142187.86270467675,0.734890336844173,-0.44439911336676974,0.4693805272864217,0.6566645281987097,Downregulated
Feature0365,NA,C20 H31 N O14,509.17464,NA,NA,Feature0365,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,1895416.27415184,1648516.82415309,0.8697386672438314,-0.20134611933784782,0.3964187184129639,0.6084566375640841,Downregulated
Feature0364,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0364,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,169206.54066595834,140663.83948085667,0.8313144333974082,-0.2665338348564431,0.0906850774783946,0.4407379248873613,Downregulated
Feature0363,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0363,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,1857309.6117335432,7709587.626909583,4.150943697380504,2.0534393636300754,0.04073295213625662,0.3917457709388165,Upregulated
Feature0362,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0362,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,93967.92285201527,81117.83327630637,0.8632502540686594,-0.21214924119990689,0.13412016419970793,0.46620185166403955,Downregulated
Feature0361,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0361,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,4875192.08295949,5184887.320968013,1.0635247253315447,0.08885357415288819,0.4789461751770121,0.6667215986955428,Upregulated
Feature0360,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,276819.35072274564,283684.2207844867,1.0247990974757277,0.035341110234170976,0.9602409237829264,0.9794457422585849,Upregulated
Feature0359,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,633210.0308305554,594861.5498069103,0.9394379760956331,-0.09013018021709686,0.7989693573651249,0.8928721304419024,Downregulated
Feature0358,NA,C16 H33 N O2,271.25118,NA,NA,Feature0358,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,197620.22093589298,194144.46789342366,0.9824119564991437,-0.02559997567249874,0.9112651813330631,0.9548277196929219,Downregulated
Feature0357,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0357,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,223921.54500439734,186369.31940470132,0.832297398631478,-0.2648289669223654,0.18195500344709642,0.48745712214463777,Downregulated
Feature0356,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,2409916.63442321,1915697.06902463,0.7949225469714779,-0.33111379618056225,0.015697878600465703,0.3605734563057726,Downregulated
Feature0355,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,742691.001053218,808109.188545739,1.0880826445988314,0.12178813969920967,0.3433254805960914,0.5724452615273762,Upregulated
Feature0354,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,350218.15460494667,222431.7976376,0.6351235500298597,-0.6548908294949489,0.3084771104958871,0.559635581528333,Downregulated
Feature0353,NA,C25 H34 O2,366.25594,NA,NA,Feature0353,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,463306.22842083935,400763.25103968364,0.8650072596815049,-0.20921585408880308,0.22729049864129133,0.4990605469188433,Downregulated
Feature0352,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,2581415.7813757365,2060175.9560431433,0.7980798641221585,-0.32539497023452846,0.16054536448603807,0.4765394152204622,Downregulated
Feature0351,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0351,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,210125.491587618,483239.7708143347,2.299767473061847,1.2014879992482397,0.1209358269506692,0.4627741841989286,Upregulated
Feature0350,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,1652933.59523449,1930453.5151771067,1.1678953835427652,0.22391104784485522,0.2738042358185189,0.5339797362775934,Upregulated
Feature0349,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0349,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,130216.53667582467,112711.99081573133,0.8655735568849364,-0.2082716691210743,0.0525013133184645,0.4299742594402713,Downregulated
Feature0348,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0348,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,87698.16201325133,73796.35818181172,0.8414812407432322,-0.24899698517215815,0.43629543795819414,0.6308448175888777,Downregulated
Feature0347,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0347,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1478298.7499800932,1326782.3043624568,0.8975062073077741,-0.15600617798936156,0.22438060343557165,0.49581507401192965,Downregulated
Feature0346,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0346,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2714214.9541416867,3337968.4999807402,1.229809928976794,0.2984353597012094,0.09429512400415246,0.4426741804713768,Upregulated
Feature0345,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0345,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,987249.5293706913,1203329.1071646367,1.2188702768302988,0.2855445895082395,0.025107582388046373,0.39036770986176245,Upregulated
Feature0344,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,1286090.0972379933,1104741.9786569653,0.8589926794627444,-0.21928225845703228,0.5303056204145836,0.7072097828449871,Downregulated
Feature0343,NA,C6 H9 O P S,160.01125,NA,NA,Feature0343,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,322317.69991775363,286370.0674948697,0.8884714291766889,-0.17060271103390767,0.14913301495124406,0.47268226304818617,Downregulated
Feature0342,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,375367.96394436137,245985.79529429934,0.6553190973184926,-0.6097305195072027,0.3482818580122517,0.5724452615273762,Downregulated
Feature0341,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0341,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,129931.04080801533,120749.259109751,0.9293334245522498,-0.10573179790678004,0.694053850340522,0.812868914490674,Downregulated
Feature0340,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,158935.19485408167,138357.32384398932,0.8705266569246359,-0.2000396186949014,0.5019783154945823,0.6852654226052726,Downregulated
Feature0339,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3970961.7158869337,3641580.84405876,0.917052619643651,-0.12492357816521572,0.6121992293842027,0.7640573252158793,Downregulated
Feature0338,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1486488.6808475733,1258972.953353451,0.8469441910823053,-0.23966118778737489,0.5601404960029042,0.7237768804931469,Downregulated
Feature0337,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,244758.01010768634,208478.88715887434,0.8517755437999751,-0.23145478709938297,0.13048633394538411,0.4627741841989286,Downregulated
Feature0336,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,3438330.20467192,3522328.39237036,1.0244299362476312,0.03482131759990705,0.725695163328574,0.8376851576694033,Upregulated
Feature0335,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,203457.78256864866,238686.771596918,1.173151346601267,0.23038914542625002,0.6299278665133607,0.7792492461168586,Upregulated
Feature0334,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1252047.57158629,1091250.7829486155,0.8715729399690845,-0.19830668959742093,0.608054077614433,0.7605760034374514,Downregulated
Feature0333,NA,C28 H40,376.313,NA,NA,Feature0333,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,203336.59360586034,228412.114475054,1.1233202564502436,0.16776929597007667,0.6903302542464167,0.8103781128808827,Upregulated
Feature0332,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0332,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,406336.9293103293,514015.07437381765,1.2649971914840454,0.3391341818867492,0.07551161714883926,0.4407379248873613,Upregulated
Feature0331,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,5040299.914133034,4362876.491097297,0.8655985884617228,-0.2082299483346177,0.583813272891943,0.7409937694397737,Downregulated
Feature0330,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,119387.0856833522,118219.80324935686,0.990222707696448,-0.014175061457390824,0.9656539541799696,0.9813025074337496,Downregulated
Feature0329,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1419908.5248943034,988595.39311671,0.6962387898828202,-0.5223459010316928,0.007573179107429023,0.3605734563057726,Downregulated
Feature0328,NA,C11 H21 N O12,359.10644,NA,NA,Feature0328,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1200181.5976290968,1040756.4286337857,0.8671657944845612,-0.20562024444644822,0.24746350175741602,0.5073945532162878,Downregulated
Feature0327,NA,C17 H33 N O15,491.18523,NA,NA,Feature0327,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,2434420.8625078634,2288083.9245741833,0.9398883980221364,-0.0894386329679698,0.6906531640890432,0.8103781128808827,Downregulated
Feature0326,NA,C8 H19 N O4,193.13145,NA,NA,Feature0326,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,138721.60935301706,94635.04639865634,0.6821939771317836,-0.5517460769639908,0.21950238138061562,0.49414252020044086,Downregulated
Feature0325,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0325,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,1487095.80263817,6695374.680627087,4.5023156334307535,2.1706672000224954,0.0768918327851112,0.4407379248873613,Upregulated
Feature0324,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,5498967.48976612,4807256.660972211,0.874210780463565,-0.19394692584016274,0.08103581176241785,0.4407379248873613,Downregulated
Feature0323,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0323,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,700549.372674498,1008836.4526715733,1.4400647435028355,0.5261336748833866,0.1590816495901749,0.47628186389725785,Upregulated
Feature0322,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0322,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,3016727.338093707,2949221.7903993265,0.977622920427062,-0.0326499852638384,0.48149551685839675,0.668084909379413,Downregulated
Feature0321,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2236403.3579825135,1575714.7981854668,0.704575403431221,-0.5051739833346245,0.027400197732607556,0.39036770986176245,Downregulated
Feature0320,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,709250.3980745054,912291.9263181337,1.286276227401284,0.3632004942278945,0.19725053520146785,0.48745712214463777,Upregulated
Feature0319,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,4341938.525822117,3891295.0576932,0.8962114582118386,-0.15808892318413156,0.1791114829711412,0.48745712214463777,Downregulated
Feature0318,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,310127.3511836843,264785.444692466,0.8537958476794815,-0.22803694863676902,0.6905897385928677,0.8103781128808827,Downregulated
Feature0317,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,180414.77717697967,159342.52093039433,0.8832010516194342,-0.17918620496643503,0.6659339795217014,0.7974150747314289,Downregulated
Feature0316,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0316,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,742361.2464599507,314522.613284663,0.4236786534648816,-1.2389576527943995,0.41722894379308273,0.615243020119386,Downregulated
Feature0315,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0315,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1021711.0815573146,1175815.5363761133,1.1508297772242122,0.20267445578483145,0.02218227492327242,0.39036770986176245,Upregulated
Feature0314,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,800559.8698464833,1039444.2082247777,1.2983965939038429,0.37673112036783807,0.13495993288893007,0.4673612490783319,Upregulated
Feature0313,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,1031131.8213592833,633854.747949162,0.6147174733814217,-0.7020046005402596,0.019134051691760728,0.376638701722027,Downregulated
Feature0312,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0312,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,2976968.1356609534,2908041.9896282735,0.9768468646986789,-0.03379567891247159,0.810902774378021,0.8996655060370997,Downregulated
Feature0311,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0311,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,441017.97489993664,382874.25372123433,0.8681602009716393,-0.20396680818338075,0.08887115808994943,0.4407379248873613,Downregulated
Feature0310,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,600593.1799749407,485423.8616378686,0.808240715717289,-0.30714306471732666,0.07918660195461628,0.4407379248873613,Downregulated
Feature0309,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,1478580.7003781267,1618532.83796951,1.0946530260780438,0.13047364892911745,0.34873390200148896,0.5724452615273762,Upregulated
Feature0308,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,234613.45011069134,199837.999005885,0.8517755436084369,-0.2314547874238009,0.13048633349434127,0.4627741841989286,Downregulated
Feature0307,NA,C7 H16 O6,196.09463,NA,NA,Feature0307,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,1995070.60511538,1544976.33159967,0.7743968196605855,-0.36885506720941497,0.1302874572269268,0.4627741841989286,Downregulated
Feature0306,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,117019.73927594701,105055.80847662267,0.8977614300514556,-0.1555959788842815,0.2796939136481391,0.5393007678750934,Downregulated
Feature0305,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,325553.73075356765,371157.64136331534,1.1400810566789916,0.18913639975111554,0.797569123070565,0.8928721304419024,Upregulated
Feature0304,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0304,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,217312.17944342768,4149806.1705887,19.096058864335344,4.255203013589453,0.037044371259647255,0.3917457709388165,Upregulated
Feature0303,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,7401144.85150982,677212.3869843424,0.09150103133654955,-3.450068185222414,0.1928069896940024,0.48745712214463777,Downregulated
Feature0302,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0302,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,7119806.781065706,6073980.579181197,0.8531103112705584,-0.229195793867356,0.06754108781436835,0.43620489220914954,Downregulated
Feature0301,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0301,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,225687.49666723135,179930.44156629033,0.7972548068606199,-0.32688720399267657,0.1783807969864065,0.48745712214463777,Downregulated
Feature0300,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,2131155.22620158,1774105.6077379,0.8324619370405694,-0.2645437860646662,0.31204759127061216,0.5612627169376326,Downregulated
Feature0299,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,806120.1413998593,908878.6063957177,1.127472891097119,0.1730927458088828,0.45071349956296874,0.647503900780603,Upregulated
Feature0298,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0298,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,915998.84716698,826236.6851706933,0.9020062500363347,-0.14879066488210943,0.3553777008734151,0.5729208247262728,Downregulated
Feature0297,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,176638.072204646,313614.45923168166,1.7754635527743992,0.8281957446048229,0.1311605976606589,0.4627741841989286,Upregulated
Feature0296,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1369623.4218800534,1091086.5877521553,0.7966325417058389,-0.3280136812174798,0.11055208922036706,0.45172120667857957,Downregulated
Feature0295,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,147708.700679287,119960.756736148,0.8121441471251798,-0.3001922814102037,0.09970476847312512,0.44747500090738557,Downregulated
Feature0294,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1202178.9611033767,1298416.6187501466,1.0800526882939638,0.1111016932093984,0.69120486098663525,0.8103781128808827,Upregulated
Feature0293,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,371909.656351484,311261.50946545234,0.8369277434713489,-0.2568250224527339,0.57264918087766,0.7335520513857691,Downregulated
Feature0292,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1342180.46512154,1398217.9521330732,1.041751082263337,0.0590105988406902,0.7491127108108984,0.856783345086471,Upregulated
Feature0291,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0291,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,263440.01239786064,213718.07073836133,0.8112589609796758,-0.3017655860103599,0.10536388657601378,0.45172120667857957,Downregulated
Feature0290,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,6026731.09838039,6299230.4263277305,1.045215113052011,0.06379989024469764,0.6078395640600436,0.7605760034374514,Upregulated
Feature0289,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,347540.5381760867,220025.649247744,0.6330934814178848,-0.6595095538110987,0.20614528553127265,0.48745712214463777,Downregulated
Feature0288,NA,C8 H19 N O7,241.11608,NA,NA,Feature0288,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,1052169.7483503525,1020646.6592609223,0.9700399207078005,-0.043883974162786527,0.6272624109773818,0.7784616783224064,Downregulated
Feature0287,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,851283.6416892523,1387964.14729066,1.6304367655138314,0.7052584890172767,0.07854379080249362,0.4407379248873613,Upregulated
Feature0286,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0286,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,1871687.33560967,2258139.41278269,1.2064725607854476,0.2707951042242645,0.35164154073370124,0.5724452615273762,Upregulated
Feature0285,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,131949.43610735633,114886.23662302199,0.8706838014036572,-0.19977921184963096,0.32468849840999153,0.5692978351524217,Downregulated
Feature0284,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2919105.78794523,2705570.39708132,0.9268490399540408,-0.10959371509251538,0.12712437049024072,0.4627741841989286,Downregulated
Feature0283,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,465443.7981059473,453878.1055292467,0.9751512585971379,-0.0363020779710315,0.951455271965491,0.9758069608274962,Downregulated
Feature0282,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,7174355.353504163,6147794.775755047,0.8569124991491097,-0.2227801991710312,0.24825263734560424,0.5073945532162878,Downregulated
Feature0281,NA,C31 H37 N O11,599.23689,NA,NA,Feature0281,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,232682.538457207,198193.29572781667,0.8517755438028569,-0.2314547870945019,0.13048633400335435,0.4627741841989286,Downregulated
Feature0280,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0280,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,301151.7227124614,193891.795454113,0.6438342563932141,-0.6352387547698087,0.3520845079294694,0.5724452615273762,Downregulated
Feature0279,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0279,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5555161.5065744035,5372416.842893116,0.9671036272365775,-0.04825760902157694,0.4601188076096208,0.6519708164262784,Downregulated
Feature0278,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,420823.8047811933,742173.117817789,1.763619617962631,0.8185394302518186,0.09298126149433074,0.4408310796245394,Upregulated
Feature0277,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0277,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,7440933.174192723,6804405.575804276,0.9144559447736871,-0.12901442714137207,0.03823909874294105,0.3917457709388165,Downregulated
Feature0276,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3551591.0519515,3191629.7548802034,0.898647875893958,-0.15417217071254383,0.43883977261838214,0.6326672985317091,Downregulated
Feature0275,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,1067745.9570165647,767848.206978844,0.7191300532987472,-0.4756753919806252,0.38106370196626366,0.5935274737865623,Downregulated
Feature0274,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,7560614.850584763,7000851.898185044,0.9259633027919117,-0.1109730762714072,0.4527102181434398,0.6487111938147375,Downregulated
Feature0273,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0273,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,4304487.609726616,4099510.2781201834,0.952380550209215,-0.07038993711325628,0.431733887637579,0.6274681631209373,Downregulated
Feature0272,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,111957.84624536634,106856.93600749686,0.9544390106729068,-0.06727508354517323,0.7100940762421459,0.8266819790819587,Downregulated
Feature0271,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,2728233.0183519535,2302763.489488017,0.8440494173327796,-0.24460062669680624,0.16301490479264738,0.4813229557298694,Downregulated
Feature0270,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0270,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,277101.756828544,218058.180910089,0.7869245702581811,-0.3457027403868749,0.20642471699435674,0.48745712214463777,Downregulated
Feature0269,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,395625.53319456865,163179.53058065134,0.4124595530096882,-1.277675443488582,0.025523940394340704,0.39036770986176245,Downregulated
Feature0268,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0268,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,939335.8546663737,2069694.8672310933,2.2033598067713407,1.1397051051426499,0.23245256067747977,0.5030930259325901,Upregulated
Feature0267,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1160656.0158708468,989902.1763356724,0.8528816141903535,-0.22958259539968412,0.10764413265861435,0.45172120667857957,Downregulated
Feature0266,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,719823.404622927,764806.3740357717,1.0624916738243717,0.08745153566977028,0.6738866333513728,0.8019811300775679,Upregulated
Feature0265,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1183101.8579958966,1925159.1410172828,1.627213352769462,0.7024034229850699,0.6316680902395335,0.780256870266987,Upregulated
Feature0264,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,415055.5586530083,319285.653921198,0.7692600358308291,-0.3784567346854832,0.5535713627136964,0.7237768804931469,Downregulated
Feature0263,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0263,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,160709.624325224,2710645.82188074,16.866729875463307,4.076108385657723,0.041665227207453484,0.3917457709388165,Upregulated
Feature0262,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,605383.641552159,341514.30943444633,0.5641287375371241,-0.8259036630921226,0.4854381249130159,0.6715925723210898,Downregulated
Feature0261,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,141188.30637596064,208794.35144034913,1.478836008446514,0.5644620775090071,0.4720519543510208,0.65957944306581,Upregulated
Feature0260,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2705776.0670469967,2404407.15618105,0.8886201579885908,-0.17036122621520844,0.3140083694717616,0.5612627169376326,Downregulated
Feature0259,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,5394057.57849583,6484413.306118987,1.2021401721720608,0.2656051272529797,0.0965381203680562,0.4438331226509661,Upregulated
Feature0258,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,522208.3772307873,296023.1841683637,0.5668679344788408,-0.8189154310867551,0.06437242429881217,0.43620489220914954,Downregulated
Feature0257,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,3521367.3803601298,3090390.321567763,0.8776108788886746,-0.18834668534787052,0.20594948224194523,0.48745712214463777,Downregulated
Feature0256,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,608716.0968487824,533958.9378124774,0.8771887922410629,-0.1890407159373411,0.5541740345397129,0.7237768804931469,Downregulated
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1453698.46340999,1630661.97725194,1.1217333018477853,0.1657297081767756,0.3345031669547111,0.5724452615273762,Upregulated
Feature0254,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3170260.4259058833,2753171.4929339765,0.8684370124411069,-0.20350688053342253,0.2380126374850768,0.5073945532162878,Downregulated
Feature0253,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1987201.1398573534,4069926.87050812,2.048069915459222,1.034264965808922,0.0263467958267527,0.39036770986176245,Upregulated
Feature0252,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5498749.98511644,4671042.254856084,0.8494734744258737,-0.23535919622621704,0.06677535674652905,0.43620489220914954,Downregulated
Feature0251,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,1051577.390880538,1205975.89014979,1.1468256170284972,0.19764603601406466,0.2802249087978426,0.5393007678750934,Upregulated
Feature0250,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,804659.924864985,1041393.2096595691,1.2942029017218744,0.37206381699068736,0.1681499440865108,0.48569146941833746,Upregulated
Feature0249,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,546123.222840936,857915.6838281814,1.5709196165753567,0.6516093603042332,0.2055175804217086,0.48745712214463777,Upregulated
Feature0248,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,5819619.6723811105,4984734.247472056,0.8565395211526841,-0.22340828038711108,0.0015769294822488317,0.18697901200665257,Downregulated
Feature0247,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,119855.69838354267,99133.76740270737,0.8271093384769712,-0.2738500379795588,0.02329112650197433,0.39036770986176245,Downregulated
Feature0246,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,1030996.4758449683,650034.8225654477,0.630491798754891,-0.6654504903490938,0.3300498915188746,0.5724452615273762,Downregulated
Feature0245,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0245,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,533609.380004828,776844.0193500116,1.4558290173665667,0.5418409253975834,0.077518309687212,0.4407379248873613,Upregulated
Feature0244,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,205063.217737325,3604961.93089807,17.579758918617152,4.135843380994372,0.2047982959553879,0.48745712214463777,Upregulated
Feature0243,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,226858.25416901332,410830.87897576264,1.810958479252364,0.856753469279024,0.013118833103016538,0.3605734563057726,Upregulated
Feature0242,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,3048608.972454483,2722405.9269944835,0.8929993815515905,-0.16326891868169546,0.32493200661515154,0.5692978351524217,Downregulated
Feature0241,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,232660.76901028902,166654.32644598433,0.7162974968015099,-0.4813691945213518,0.48917579886170803,0.6742693443769489,Downregulated
Feature0240,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,4871494.856736586,1954743.6055180333,0.4012615558476676,-1.3173851541812427,0.3718435318529769,0.585966913959326,Downregulated
Feature0239,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1598717.3438846034,511076.37096989865,0.3196790057509932,-1.6453040936324508,0.035635942548457845,0.3917457709388165,Downregulated
Feature0238,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0238,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,3083025.4813403,2908412.2191603766,0.9433630168687375,-0.0841150516050911,0.7102686522593655,0.8266819790819587,Downregulated
Feature0237,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,344113.85222997033,713978.871871709,2.07483327754722,1.0529954138959927,0.04361127996576074,0.3917457709388165,Upregulated
Feature0236,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4142727.3979407535,3611161.0066596903,0.8716868525924995,-0.1981181449205683,0.3607945140349259,0.5766544796968475,Downregulated
Feature0235,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,666143.4364127157,241567.30420863233,0.3626355691643668,-1.4634076559048057,6.59237198125163e-5,0.03958000130647323,Downregulated
Feature0234,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,638355.5065942823,727222.377562925,1.1392121945383695,0.18803649462785987,0.6367697075652349,0.780256870266987,Upregulated
Feature0233,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,130116.73079564967,112264.55554663666,0.8627987719961231,-0.21290397174593115,0.12227185257502635,0.4627741841989286,Downregulated
Feature0232,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0232,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1381733.82623551,1512980.2256556833,1.0949867455859787,0.13091340663639323,0.4960547649395522,0.6795768574629762,Upregulated
Feature0231,NA,C9 H15 N O5,217.09502,NA,NA,Feature0231,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,1170054.9646536866,1272712.921337834,1.087737721547579,0.12133073173719122,0.5616301338123808,0.7243092070545876,Upregulated
Feature0230,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,2507768.46777546,2147419.2848953665,0.8563068371300862,-0.22380025026337905,0.10594013603678759,0.45172120667857957,Downregulated
Feature0229,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,439107.965059322,360504.8648036643,0.820993681485512,-0.2845569760811099,0.23091159911693024,0.5030930259325901,Downregulated
Feature0228,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,273626.851797245,204175.84431296433,0.7461835085697539,-0.4223976194385745,0.0883297601993871,0.4407379248873613,Downregulated
Feature0227,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,93212.11376632846,110966.73428445803,1.1904754629064442,0.2515378852802325,0.31384731273588184,0.5612627169376326,Upregulated
Feature0226,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0226,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2819009.3343892167,2403061.3438295065,0.8524488778786424,-0.23031477786779994,0.012534692950832345,0.3605734563057726,Downregulated
Feature0225,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,305028.9508334493,371899.86682611966,1.2192280955953683,0.2859680534401689,0.3905925955220113,0.6007194466920363,Upregulated
Feature0224,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1153828.5821661535,1183988.5198946067,1.0261390107634811,0.03722618567621013,0.5432986196893558,0.7172130841208488,Upregulated
Feature0223,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0223,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,196267.10761379666,256688.39237259232,1.3078523217333455,0.3871996457815571,0.5506280710797614,0.7217344576536125,Upregulated
Feature0222,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2137422.21119186,1643579.33327247,0.76895398797039,-0.37903082090433754,0.019113406170840973,0.376638701722027,Downregulated
Feature0221,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,166356.92561295434,144050.5047761117,0.8659122801491251,-0.207707212433921,0.12267313255625147,0.4627741841989286,Downregulated
Feature0220,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,1774899.0300223299,822761.760026416,0.46355412116939687,-1.109190307742111,0.044840349011209105,0.393943055526956,Downregulated
Feature0219,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,2320333.4852468,2178518.8914194703,0.9388818052538488,-0.09098454478988811,0.6741723815497976,0.8019811300775679,Downregulated
Feature0218,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,498797.5403128727,410592.45107364736,0.8231645465134043,-0.28074724782403765,0.7386341145961695,0.850634488530039,Downregulated
Feature0217,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0217,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,603022.0679205867,546829.481806795,0.9068150419311158,-0.14111977268885584,0.48892823928823786,0.6742693443769489,Downregulated
Feature0216,NA,C19 H41 N O,299.31886,NA,NA,Feature0216,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,216059.47321476368,195782.86281642466,0.9061526435446595,-0.14217399877066964,0.6059026324723349,0.7595784956804019,Downregulated
Feature0215,NA,C16 H35 N O,257.27187,NA,NA,Feature0215,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,5228081.364986519,6560974.63085698,1.2549488374066071,0.32762854861879204,0.6543882302519061,0.7896744443545651,Upregulated
Feature0214,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0214,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,243272.890970359,305793.72409352334,1.2569987674080054,0.3299832350764558,0.39907095450721064,0.609776780570555,Upregulated
Feature0213,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,320877.1840109997,280897.9994918733,0.8754065838543513,-0.19197486048967596,0.1767414846879486,0.4872332821127231,Downregulated
Feature0212,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,214067.39111768632,147718.09309901998,0.6900541569071118,-0.5352185028005244,0.08958881806412305,0.4407379248873613,Downregulated
Feature0211,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,7030286.379403063,6550876.00080587,0.9318078449831371,-0.10189561819649294,0.1989415584128046,0.48745712214463777,Downregulated
Feature0210,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0210,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,138478.71174275567,119128.39802726933,0.8602650654966205,-0.21714684233144804,0.014370419224553043,0.3605734563057726,Downregulated
Feature0209,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0209,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,1621881.4949551034,1748041.6176154034,1.0777862766501274,0.10807112225887959,0.28013138668893545,0.5393007678750934,Upregulated
Feature0208,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,316330.1509409377,217839.281474034,0.6886453309179086,-0.5381669436949794,0.37044491930390483,0.585966913959326,Downregulated
Feature0207,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,2761818.56764305,2967532.549158687,1.074484973026738,0.10364530641260229,0.35692706911808986,0.5729208247262728,Upregulated
Feature0206,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,152970.90549941268,133641.918395364,0.8736427228371025,-0.19488468629656705,0.2143209047282522,0.49377424046221546,Downregulated
Feature0205,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0205,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,178227.169679201,113330.02139116466,0.635873989331438,-0.6531871988408282,0.09731100550101396,0.4438331226509661,Downregulated
Feature0204,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,510334.90605739004,342062.92418814264,0.6702714631667303,-0.5771825825319289,0.1538781303134387,0.47268226304818617,Downregulated
Feature0203,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2431980.8602078333,2249523.08313257,0.9249756525387824,-0.11251270377068318,0.06733863632117873,0.43620489220914954,Downregulated
Feature0202,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,176177.192658288,394118.09363140166,2.237055135711183,1.1616008143035352,0.028006118866206332,0.39036770986176245,Upregulated
Feature0201,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0201,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,1463220.40037165,878385.896172979,0.6003100393829076,-0.7362202995748544,0.08524447002589201,0.4407379248873613,Downregulated
Feature0200,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0200,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,525207.3853303053,448073.0225264337,0.8531354185825825,-0.2291533355110758,0.6365397012678383,0.780256870266987,Downregulated
Feature0199,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1990820.7176343733,1807199.73775453,0.9077661899671036,-0.13960733923454402,0.8149917391867673,0.8996655060370997,Downregulated
Feature0198,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,456215.02651112364,222694.30442947467,0.48813452317104866,-1.0346493053636032,0.4052921349836924,0.6115057027381818,Downregulated
Feature0197,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0197,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,473406.71812563465,3899464.0714173503,8.237027321573612,3.042123774034198,0.09922885562058692,0.44747500090738557,Upregulated
Feature0196,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,1120270.1834028133,1128780.79594431,1.0075969285513302,0.010918629437155849,0.908239573369442,0.9532692248087129,Upregulated
Feature0195,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1273864.5298016618,3428227.52719803,2.6912025941501003,1.4282510013736798,0.042908151376246234,0.3917457709388165,Upregulated
Feature0194,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,990634.7281538896,977886.6556556487,0.987131409654901,-0.018685941879535012,0.9511768839816928,0.9758069608274962,Downregulated
Feature0193,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,1763617.9867146467,2273775.9253794434,1.2892678247261153,0.3665519916036073,0.011364143287775092,0.3605734563057726,Upregulated
Feature0192,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,1149284.45531762,1244735.8446583953,1.083052884687626,0.11510369041973575,0.7128978811831019,0.8271679655506106,Upregulated
Feature0191,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,2190787.3509306633,1884940.7172404,0.86039419409632,-0.21693030533874072,0.21073344943724642,0.4885184509681622,Downregulated
Feature0190,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5557848.192313886,4998420.010938063,0.8993444653365177,-0.15305429477775512,0.2094067137911902,0.48745712214463777,Downregulated
Feature0189,NA,C14 H21 N O10,363.11672,NA,NA,Feature0189,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,100158.76019998624,84514.26619297614,0.8438030385382881,-0.24502181216983893,0.06790175506596163,0.43620489220914954,Downregulated
Feature0188,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0188,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,5663086.4057010505,6163099.237911923,1.0882933433096673,0.12206747928748223,0.18998025326261042,0.48745712214463777,Upregulated
Feature0187,NA,C19 H37 N O2,311.28246,NA,NA,Feature0187,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,184320.698319969,161824.374867312,0.8779500964476338,-0.18778915701013835,0.11904037500925428,0.4627741841989286,Downregulated
Feature0186,NA,C13 H25 N O9,339.15309,NA,NA,Feature0186,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,114854.669837102,96608.57759470987,0.8411375674296003,-0.24958632339867626,0.091541546091794615,0.4407379248873613,Downregulated
Feature0185,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0185,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,194525.80939063366,154486.806105601,0.7941712546501785,-0.3324779520105677,0.2674728138523379,0.5274244238002164,Downregulated
Feature0184,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0184,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,514358.32707776735,856168.1980953087,1.6645364778275713,0.7351204870623091,0.043295864803485566,0.3917457709388165,Upregulated
Feature0183,NA,C9 H21 N O7,255.13179,NA,NA,Feature0183,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,307178.2121119513,268540.3012032443,0.8742166293531737,-0.19393727355035562,0.10357900335471469,0.4501055128430483,Downregulated
Feature0182,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0182,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,827097.0587497914,578819.0924374866,0.6998200348002781,-0.5149441275184284,0.1164798291081404,0.4627741841989286,Downregulated
Feature0181,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,209129.82816062402,897625.302649398,4.292191652163406,2.1017144958177987,0.20125875021670106,0.48745712214463777,Upregulated
Feature0180,NA,C17 H31 N O9,393.19997,NA,NA,Feature0180,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,357396.79810455133,188680.683555133,0.5279305370271873,-0.9215799768168588,0.09531849774519151,0.4438331226509661,Downregulated
Feature0179,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1615306.28833208,1825230.3094556967,1.1299592669452048,0.1762707669454762,0.25799278160115574,0.5187596791335067,Upregulated
Feature0178,NA,C10 H23 N O6,253.15257,NA,NA,Feature0178,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,133725.090513818,136337.83987695532,1.01953821345791,0.027915850227520352,0.8545553666422027,0.9246008884981209,Upregulated
Feature0177,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,210273.48892578602,407626.076087123,1.9385519219257863,0.9549793765653276,0.0369181687738812,0.3917457709388165,Upregulated
Feature0176,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,220205.18762322134,179668.411527874,0.8159136188711995,-0.29351167335577144,0.1865776018136169,0.48745712214463777,Downregulated
Feature0175,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3630713.93061324,3466628.865453247,0.954806391168285,-0.06671987149665201,0.41732272712632307,0.615243020119386,Downregulated
Feature0174,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0174,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2363137.69744034,2204065.65313345,0.9326860874509383,-0.10053649749927687,0.34607659431815674,0.5724452615273762,Downregulated
Feature0173,NA,C20 H33 N O11,463.2054,NA,NA,Feature0173,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,135187.707855201,358931.0681400483,2.6550569858355604,1.4087428261142054,0.17621219531863527,0.4872332821127231,Upregulated
Feature0172,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,420594.52837755036,278431.13348490366,0.6619941884621179,-0.5951095429812809,0.16003410221859735,0.47628186389725785,Downregulated
Feature0171,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0171,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4681074.399593463,4874502.19888529,1.0413212401214185,0.058415198355888334,0.8557459432531063,0.9249970600481554,Upregulated
Feature0170,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,4820231.848163007,4153024.602965247,0.8615819184191248,-0.21494012179352778,0.09103128566962569,0.4407379248873613,Downregulated
Feature0169,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2395982.31783622,2532165.4988821833,1.0568381410965288,0.07975443923888624,0.6385046472475788,0.780256870266987,Upregulated
Feature0168,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,77861.60556192407,66647.48675377434,0.855973701964943,-0.22436162142399013,0.05527332395865632,0.43364536838278145,Downregulated
Feature0167,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0167,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,107585.22466227613,925198.9853890826,8.59968446683456,3.104283726502622,0.19402371844997324,0.48745712214463777,Upregulated
Feature0166,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0166,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,280803.42095858266,390426.8594346117,1.3903921045612833,0.47549179484361614,0.34489523353511575,0.5724452615273762,Upregulated
Feature0165,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,1062969.4921439188,886216.414677905,0.8337176383966413,-0.2623692371877876,0.264046370053067,0.5265330007344392,Downregulated
Feature0164,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0164,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,5311303.290856207,4809549.96749252,0.9055310352493913,-0.14316400740258214,0.1585852721075862,0.47628186389725785,Downregulated
Feature0163,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0163,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,861549.4883280777,985901.8619565329,1.144335729186925,0.19451037709467486,0.17820727027473982,0.48745712214463777,Upregulated
Feature0162,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0162,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1936408.90662586,1615093.1891359633,0.8340661848897502,-0.26176622581733633,0.17539895486426912,0.4872332821127231,Downregulated
Feature0161,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,197877.30737224466,151548.848092546,0.7658728032287903,-0.3848232867953838,0.22448668235121236,0.49581507401192965,Downregulated
Feature0160,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0160,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,591850.9706670031,695131.051100667,1.1745035246242301,0.23205104280968236,0.3775848704956185,0.5899161723680012,Upregulated
Feature0159,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,1684608.4756339735,1532103.5231884301,0.9094715747597372,-0.13689954727340153,0.3651263576780165,0.5815309269831697,Downregulated
Feature0158,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,92544.8832044746,88302.26773901573,0.9541561313975084,-0.06770273687172748,0.5998132348491875,0.7561690443829083,Downregulated
Feature0157,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,699508.6330843254,731432.304597453,1.0456372802325076,0.06438248374384783,0.8034467182634175,0.8952008122061117,Upregulated
Feature0156,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,436878.7813610355,356741.9533439227,0.8165696494403835,-0.29235214894513506,0.725361371658312,0.8376851576694033,Downregulated
Feature0155,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0155,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,66596.6407635554,60773.1821548305,0.9125562709776833,-0.1320145723279601,0.35322216905002013,0.5724452615273762,Downregulated
Feature0154,NA,C9 H9 O P S,196.01126,NA,NA,Feature0154,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,165734.48026912133,142915.138120972,0.8623138521863704,-0.21371503928248287,0.20641843700556395,0.48745712214463777,Downregulated
Feature0153,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,110492.37371541167,120582.15664160407,1.0913165550427946,0.1260696407525204,0.5231410318531334,0.7012714907278563,Upregulated
Feature0152,NA,C8 H11 N O7,233.05354,NA,NA,Feature0152,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,850780.0347730797,696378.1314039767,0.818517246458087,-0.288915279754918,0.20396871247836237,0.48745712214463777,Downregulated
Feature0151,NA,C23 H32,308.25044,NA,NA,Feature0151,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,365857.66124892666,350259.77733234735,0.9573662504064206,-0.06285714660021631,0.8943045503202636,0.9497007697011406,Downregulated
Feature0150,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0150,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,338811.71891011833,1362332.324469145,4.020912643905778,2.0075229932949696,0.04704001753451397,0.40599153595172827,Upregulated
Feature0149,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0149,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,2250705.93734356,2177617.8820308265,0.9675266083853685,-0.047626756878115434,0.4681331900731845,0.6557371276680563,Downregulated
Feature0148,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0148,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,185277.56650056434,178945.53019305065,0.9658240529217313,-0.050167701993071474,0.9394433472912218,0.9705851157097153,Downregulated
Feature0147,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,620209.756573439,336112.22612419433,0.5419331485224633,-0.8838131994771398,0.09881358653021438,0.44747500090738557,Downregulated
Feature0146,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0146,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,95963.8727912617,445349.512221038,4.640803869907913,2.214374727482185,0.378030060545983,0.5899161723680012,Upregulated
Feature0145,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0145,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,734714.980421819,951470.2884228673,1.2950195841611987,0.37297391548603953,0.06751789811502508,0.43620489220914954,Upregulated
Feature0144,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,301254.7931371127,274718.55372958136,0.911914299748739,-0.13302984630549067,0.9033669637922541,0.9518635835741798,Downregulated
Feature0143,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1811920.2431551632,1525493.06143006,0.8419206458964568,-0.24824383447780954,0.2092248668778622,0.48745712214463777,Downregulated
Feature0142,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,4557229.455251424,3752073.0357222934,0.8233232652787922,-0.28046910088023347,0.025889405853558565,0.39036770986176245,Downregulated
Feature0141,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,3853311.16262548,2794649.36847307,0.7252591993035197,-0.46343140497371205,0.024953530392637018,0.39036770986176245,Downregulated
Feature0140,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0140,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,113185.48085061634,141035.46354045838,1.2460561414815987,0.3173690709401121,0.3415968744218423,0.5724452615273762,Upregulated
Feature0139,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,779445.5382784146,609240.5200389153,0.7816332124814822,-0.3554363245304961,0.058875443651449665,0.43620489220914954,Downregulated
Feature0138,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,2117819.012860377,1869383.92401541,0.8826929556603497,-0.18001641055937945,0.4642821524853852,0.6526910819559771,Downregulated
Feature0137,NA,C9 H19 N O8,269.11107,NA,NA,Feature0137,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,297237.209514623,194066.042571847,0.6528995575242731,-0.6150670311515096,0.249097779120315,0.5073945532162878,Downregulated
Feature0136,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,3094864.11106746,3476421.6493544,1.1232873317191738,0.167727009683419,0.356601739878667,0.5729208247262728,Upregulated
Feature0135,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3625103.53463281,3251268.962158357,0.8968761667348297,-0.15701929142677362,0.24448273556003192,0.5073945532162878,Downregulated
Feature0134,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,842729.9379916914,778278.0782653077,0.9235201494324755,-0.1147846565067342,0.5648676133654728,0.7276480622228019,Downregulated
Feature0133,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,523039.28845708596,433970.44205477537,0.8297090708710337,-0.2693225362454609,0.45953629667580365,0.6519708164262784,Downregulated
Feature0132,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,148113.42942212266,128425.39529546167,0.8670746183956745,-0.20577194116672856,0.21551960653948884,0.49414252020044086,Downregulated
Feature0131,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0131,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,299187.403432596,396875.83030437736,1.326512499359919,0.4076382697464885,0.24417957891192887,0.5073945532162878,Upregulated
Feature0130,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,283469.77417804097,265157.983971364,0.9354012601175046,-0.096342722615381,0.5775485925214848,0.7359196905438647,Downregulated
Feature0129,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,3411680.1903253067,2650827.733529703,0.7769859968254951,-0.36403949688817516,0.17779025795615006,0.48745712214463777,Downregulated
Feature0128,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,736370.1830018177,532136.16152771,0.7226476218231076,-0.4686357646890684,0.07406269358219693,0.4407379248873613,Downregulated
Feature0127,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0127,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,138197.997620645,115780.00608762834,0.8377835285677996,-0.2553505748356496,0.10681402483120887,0.45172120667857957,Downregulated
Feature0126,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,169980.05632462466,147072.75290351265,0.8652353463316657,-0.20883549184382968,0.011264376738254773,0.3605734563057726,Downregulated
Feature0125,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,543521.8743844817,1814039.2684044533,3.3375644180996122,1.738795682425952,0.036479314855735585,0.3917457709388165,Upregulated
Feature0124,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,4584017.66596457,3834376.3231034633,0.8364663058724563,-0.2576206673909196,0.08825972797484949,0.4407379248873613,Downregulated
Feature0123,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0123,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,1967082.41815152,2663674.9414720866,1.3541247264947642,0.4373606296131279,0.057947444473274365,0.43620489220914954,Upregulated
Feature0122,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,1702615.43848463,1707717.7115081432,1.0029967266290352,0.00431689759140562,0.9837027880974246,0.9898785006684399,Upregulated
Feature0121,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1768118.6297026034,2901828.5725531233,1.641195632354832,0.7147472199643331,0.027062060563954857,0.39036770986176245,Upregulated
Feature0120,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0120,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,3733226.2092286535,3626675.5979718934,0.9714588387402393,-0.041775225585609636,0.5705384816072969,0.7327323627630757,Downregulated
Feature0119,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0119,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,1362168.29722593,1894354.0795618333,1.3906901837458008,0.4758010538430715,0.02992123266320104,0.39036770986176245,Upregulated
Feature0118,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,97603.53024066887,82816.0455898764,0.8484943668089692,-0.2370230132027969,0.14485440338964703,0.47109171189328686,Downregulated
Feature0117,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,364790.8142499237,262858.74960201303,0.7205739271217628,-0.47278164391734556,0.536404968993639,0.7118993857057889,Downregulated
Feature0116,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,3999903.3004963,3656243.1821817667,0.9140828933859744,-0.12960309322085073,0.16868226801769662,0.48569146941833746,Downregulated
Feature0115,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0115,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,1106976.6025847634,2086842.84313825,1.8851733977624485,0.9146972283145245,0.0287628930657043,0.39036770986176245,Upregulated
Feature0114,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,197145.75919627468,273905.10657403135,1.3893532769393049,0.4744134863493839,0.5311693727479344,0.7072097828449871,Upregulated
Feature0113,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,169990.56996264067,136846.05001937234,0.8050214200084593,-0.31290092392240704,0.07433513882763329,0.4407379248873613,Downregulated
Feature0112,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,196927.60194219733,156638.27322569868,0.7954104537954793,-0.3302285717940373,0.07307750257601171,0.4407379248873613,Downregulated
Feature0111,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,513241.56633627065,366805.28490231134,0.7146835115493827,-0.4846235906217945,0.1299651892832257,0.4627741841989286,Downregulated
Feature0110,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,587739.933839116,466077.2884212423,0.7929991848211273,-0.3346087120036591,0.37497730964767745,0.5884259320625093,Downregulated
Feature0109,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0109,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,212775.18704798867,137349.78674472033,0.6455159957807621,-0.6314752491648797,0.1260475451197815,0.4627741841989286,Downregulated
Feature0108,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5059757.49664515,5009034.6005386505,0.9899752317892446,-0.014535664060596655,0.9424224239058809,0.9718731246529397,Downregulated
Feature0107,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,186146.22375468566,207670.86714622367,1.1156329844214536,0.1578624943352524,0.6427409932733655,0.7830134576033835,Upregulated
Feature0106,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1048797.2924316814,1349059.2569004723,1.2862917044461668,0.3632178532687376,0.7810521976212831,0.8798600057540961,Upregulated
Feature0105,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,81427.63945972933,69318.3869737691,0.8512881797101713,-0.23228049639605156,0.0751091582215345,0.4407379248873613,Downregulated
Feature0104,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0104,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1294538.88594021,1320793.3370987533,1.0202809289421035,0.02896644532285664,0.8197998814285578,0.9015260366328117,Upregulated
Feature0103,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0103,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,5394966.12300103,4923048.531812063,0.9125263105588409,-0.1320619386752455,0.43925831154741657,0.6326672985317091,Downregulated
Feature0102,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4444527.022987103,3849881.1447894,0.8662071632994482,-0.20721599173394906,0.15587561259164784,0.47268226304818617,Downregulated
Feature0101,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0101,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,284017.2924045893,484027.140329778,1.704217149004681,0.7691091734936216,0.012194802811127621,0.3605734563057726,Upregulated
Feature0100,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0100,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,125848.10858394866,132056.05827238498,1.0493289073494119,0.06946695496682166,0.7694193097602462,0.8711286231594312,Upregulated
Feature0099,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2394458.4448660333,2321738.761376643,0.9696300081359488,-0.044493746820101376,0.6019704290945287,0.7571870195561224,Downregulated
Feature0098,NA,C9 H19 N O8,269.11113,NA,NA,Feature0098,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5539738.02732795,5039507.20610585,0.9097013579424833,-0.13653508817879734,0.19324774774161346,0.48745712214463777,Downregulated
Feature0097,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,301581.923390344,251311.84733852764,0.8333120384448549,-0.2630712727408468,0.44215567025095154,0.6360239256686765,Downregulated
Feature0096,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,3370105.3440978867,3428080.483585283,1.0172027677380855,0.02460729261900732,0.9299623944618469,0.9674295353109107,Upregulated
Feature0095,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0095,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,470167.79943313467,578326.987502666,1.230043801808493,0.29870969078950504,0.23304425769419945,0.5030930259325901,Upregulated
Feature0094,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,134052.28815679657,83576.54734411326,0.6234622958942447,-0.6816257796939336,0.218255892939566,0.49414252020044086,Downregulated
Feature0093,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,130911.0050591113,118693.53995083581,0.90667350615207,-0.1413449662443026,0.7875179279338622,0.8844795947365299,Downregulated
Feature0092,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,703072.5076684364,611106.855589677,0.8691946405588515,-0.2022488159767774,0.5089225575105715,0.6871399222855217,Downregulated
Feature0091,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0091,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2071460.9226692633,2792564.345074997,1.3481134567947954,0.4309419183797385,0.06108224599973851,0.43620489220914954,Upregulated
Feature0090,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,124892.43925610432,108540.89735238033,0.8690750056519151,-0.20244740045715787,0.09064649036602161,0.4407379248873613,Downregulated
Feature0089,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0089,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4082667.461542283,3958234.4408764034,0.9695216370576325,-0.044654999208807535,0.7565768952879189,0.861900610379786,Downregulated
Feature0088,NA,C14 H27 N O10,369.16362,NA,NA,Feature0088,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1583093.15652738,1378097.0074451733,0.8705091053947328,-0.2000687065582298,0.16999007550347184,0.48603027309044494,Downregulated
Feature0087,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0087,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,1094860.984325242,1102454.4011549533,1.0069355077388122,0.009971284491739755,0.9579567694009989,0.9793905680146824,Upregulated
Feature0086,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,157446.07868736066,119430.88596046134,0.7585510350982716,-0.3986818470369469,0.20434331938806274,0.48745712214463777,Downregulated
Feature0085,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1858155.9391334401,1643108.8189430367,0.8842685289961769,-0.17744355035802803,0.4078209184929461,0.6115057027381818,Downregulated
Feature0084,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0084,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,249907.95384580598,302489.066090671,1.2104019157281714,0.27548617605240455,0.2464755730570351,0.5073945532162878,Upregulated
Feature0083,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0083,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2271218.454346697,2920931.1759180236,1.2860635093589943,0.3629618886805534,0.09640571430276912,0.4438331226509661,Upregulated
Feature0082,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,103775.68313522493,110601.57368621814,1.065775433557963,0.09190348404228996,0.7580804941715397,0.862643320953821,Upregulated
Feature0081,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,184950.4637580267,145338.82916026434,0.7858257081767213,-0.3477187287548276,0.01975678798280294,0.38219165718456727,Downregulated
Feature0080,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,142038.564940039,131099.42418907868,0.9229847136545047,-0.11562134053468998,0.11071598202906362,0.45172120667857957,Downregulated
Feature0079,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0079,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1760291.46533143,1905567.1832057633,1.082529354220882,0.11440614607413714,0.3036701011032823,0.5562754908895005,Upregulated
Feature0078,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0078,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,1438388.9872904767,3951557.101698723,2.7472103419968152,1.4579673755532359,0.0630088704416452,0.43620489220914954,Upregulated
Feature0077,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,265666.4445331397,270060.383792431,1.0165393084061212,0.02366600361954265,0.9611648725355684,0.9794977175158107,Upregulated
Feature0076,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0076,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,385120.4474622807,365757.16854318,0.9497214986981516,-0.07442358286815573,0.8605120315105752,0.9283600955335244,Downregulated
Feature0075,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,3876159.2311017867,3581758.94924036,0.9240484551049405,-0.11395958945088541,0.12688161639827472,0.4627741841989286,Downregulated
Feature0074,NA,C10 H15 N O5,229.09499,NA,NA,Feature0074,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,125019.40167460234,113778.54386942516,0.9100870932462577,-0.13592348036490876,0.38984466311956806,0.6007194466920363,Downregulated
Feature0073,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0073,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,1113503.9069592417,1261661.2309843434,1.1330550553968777,0.1802179637341591,0.35039153112514904,0.5724452615273762,Upregulated
Feature0072,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0072,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,392817.8075371787,433338.62666796066,1.103154231690341,0.14163450782829498,0.462539010584062,0.6519708164262784,Upregulated
Feature0071,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,312275.828449702,263447.41773709934,0.8436369188258597,-0.24530586386014375,0.16955424012219114,0.48603027309044494,Downregulated
Feature0070,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,755865.879150004,827559.744960003,1.0948499830295568,0.13073320446916548,0.31630423696388055,0.5621927890301036,Upregulated
Feature0069,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0069,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,109480.51843285284,162437.25484555366,1.483709222158831,0.5692083797929387,0.11046986351968768,0.45172120667857957,Upregulated
Feature0068,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,2613160.58114891,2750943.1786400964,1.0527264181486347,0.074130558431662,0.5499554271575833,0.7216958938839865,Upregulated
Feature0067,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0067,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,296592.9336212283,325612.6081178757,1.0978434453657877,0.13467233786066782,0.3406395724005825,0.5724452615273762,Upregulated
Feature0066,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0066,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,394823.3191627547,446112.137510354,1.129903214572939,0.1761991993344594,0.739010662171659,0.850634488530039,Upregulated
Feature0065,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,624339.1998984714,880703.510037828,1.4106170334668175,0.49632636574471806,0.418935532416409,0.615243020119386,Upregulated
Feature0064,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,409042.0390238047,356226.48872022197,0.8708798967714194,-0.19945432471962948,0.5892160447119507,0.7461629821295809,Downregulated
Feature0063,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0063,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1007006.1327236147,3763670.6106489766,3.7374852926362094,1.902067902178287,0.043643691058246045,0.3917457709388165,Upregulated
Feature0062,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0062,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,1190713.92529865,871631.1945886733,0.7320240202700697,-0.4500371057278452,0.14875840675653498,0.47268226304818617,Downregulated
Feature0061,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,3900933.2144546364,3167420.166425683,0.8119647254377563,-0.3005110417890179,0.0606423171548205,0.43620489220914954,Downregulated
Feature0060,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,525004.838948913,598121.1588690464,1.1392678971617023,0.1881070345450226,0.507673896300272,0.6871399222855217,Upregulated
Feature0059,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0059,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,185460.95074575802,426862.33597087266,2.301629179913153,1.2026554167047585,0.1467711217440988,0.47268226304818617,Upregulated
Feature0058,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0058,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,508447.4268425743,210875.07154855234,0.41474311878825487,-1.2697100499869123,0.19225305581815763,0.48745712214463777,Downregulated
Feature0057,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0057,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,176343.289118144,76347.20991050996,0.43294650050084943,-1.2077393337476603,0.0027859965170991116,0.24540365498606226,Downregulated
Feature0056,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,289364.8848671737,266906.50841175666,0.922387346807039,-0.11655537247003599,0.7417246708263574,0.8509437710669626,Downregulated
Feature0055,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,2063901.6372277266,2607997.7370719267,1.2636250148892951,0.3375684022635223,0.18291683935552341,0.48745712214463777,Upregulated
Feature0054,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1878272.4445757132,1710569.8722579633,0.910714458489736,-0.13492930638637024,0.0914882075658512,0.4407379248873613,Downregulated
Feature0053,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0053,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1088535.1325292834,1253550.97191288,1.151594408349661,0.20363268892037664,0.19740098196497005,0.48745712214463777,Upregulated
Feature0052,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,442757.89835295366,409470.367481635,0.9248177593327024,-0.11275899262055482,0.635097079454993,0.780256870266987,Downregulated
Feature0051,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,131121.64599631,111696.648880569,0.851855145897973,-0.23131996732558588,0.1539828350812555,0.47268226304818617,Downregulated
Feature0050,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,298705.500245249,221223.50296418666,0.7406073968592926,-0.4332191363055421,0.010778055014196812,0.3605734563057726,Downregulated
Feature0049,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0049,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,440962.933174056,368327.28881205356,0.8352794783925028,-0.25966910133762755,0.6861512467386515,0.8103781128808827,Downregulated
Feature0048,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0048,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,2112842.896524283,2006153.3574713499,0.9495042725474563,-0.0747536027072616,0.8033791919533069,0.8952008122061117,Downregulated
Feature0047,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0047,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,156074.89162615698,132728.543645506,0.8504157347962668,-0.2337598043417992,0.20883195805939953,0.48745712214463777,Downregulated
Feature0046,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0046,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,4648702.553398526,4050394.3648341834,0.8712956611674503,-0.19876573597094035,0.23187458928267424,0.5030930259325901,Downregulated
Feature0045,NA,C15 H33 N O,243.2562,NA,NA,Feature0045,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1536392.6805422853,1584515.646120331,1.0313220481895684,0.04449490959841512,0.9639716373924332,0.9813025074337496,Upregulated
Feature0044,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,2643166.2257339065,2306553.9795058602,0.8726480979702357,-0.19652810158689865,0.13102722627952698,0.4627741841989286,Downregulated
Feature0043,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0043,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,154077.250795528,125247.09467679533,0.8128850562307057,-0.29887672847841457,0.10021501908390192,0.4478197055649527,Downregulated
Feature0042,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0042,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,304923.171081128,349250.623762859,1.145372529495101,0.19581690753107955,0.3105577973690594,0.5612627169376326,Upregulated
Feature0041,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1592793.1509719433,1198530.6714278634,0.7524710102479435,-0.41029209331690075,0.11578157363074487,0.4627741841989286,Downregulated
Feature0040,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0040,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2811087.2223885334,2441562.944519757,0.868547558778771,-0.20332324660138398,0.2385510547542412,0.5073945532162878,Downregulated
Feature0039,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,4643673.242255193,4108489.8080110066,0.8847499799567561,-0.17665827091986191,0.09304294075107208,0.4408310796245394,Downregulated
Feature0038,NA,C12 H17 N O4,239.11576,NA,NA,Feature0038,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,3302450.2960223034,1460217.4824281032,0.44216183486149324,-1.1773535903851156,0.0016664796079024291,0.18697901200665257,Downregulated
Feature0037,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1550208.75665712,1546830.7161924932,0.9978209125383143,-0.003147188921303489,0.9768379543906387,0.9856224683689717,Downregulated
Feature0036,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0036,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,434019.3201751583,259068.68639926368,0.59690588496086,-0.7444246173402301,0.2756919389539201,0.5351667050281977,Downregulated
Feature0035,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0035,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,85926.0722052284,263472.004388668,3.066263796620234,1.6164818201879527,0.07184489304392744,0.4407379248873613,Upregulated
Feature0034,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0034,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1154068.5847343267,1099438.8147501233,0.952663324600609,-0.06996164543919559,0.37105239841852905,0.585966913959326,Downregulated
Feature0033,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,382530.3746047417,137382.05830818234,0.35914026029994484,-1.477380703986357,0.21648535196042007,0.49414252020044086,Downregulated
Feature0032,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0032,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2699578.0647866335,2354151.50756466,0.8720442421251949,-0.19752676461512209,0.3407655151675053,0.5724452615273762,Downregulated
Feature0031,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0031,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,892138.6800900233,891157.9903862916,0.9989007429835541,-0.0015867649374049072,0.9779218788531134,0.9858296029408745,Downregulated
Feature0030,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3389179.126283163,3104632.4780991934,0.9160426057220452,-0.12651339434412792,0.3256810958105998,0.5692978351524217,Downregulated
Feature0029,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,160506.09661368566,142842.98643276532,0.8899536494029082,-0.16819789534528576,0.31868166989494995,0.5648670357379681,Downregulated
Feature0028,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0028,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2635060.58651869,2610799.4288419434,0.9907929412322168,-0.013344504548495575,0.8708152055951407,0.9358761117602948,Downregulated
Feature0027,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0027,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,348246.80972064135,247224.671013316,0.7099122349796574,-0.49428741672928683,0.3107869107570024,0.5612627169376326,Downregulated
Feature0026,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,353509.316681518,248570.087600099,0.7031500327445108,-0.5080955415746775,0.12998663789238266,0.4627741841989286,Downregulated
Feature0025,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0025,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,418133.8122984507,633085.7137772747,1.5140744306164797,0.5984361287330704,0.11733474723440074,0.4627741841989286,Upregulated
Feature0024,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0024,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2691721.8118808935,2098803.9594879434,0.7797254345616655,-0.35896189902802644,0.15004937598741566,0.47268226304818617,Downregulated
Feature0023,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0023,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,446284.08460325236,632946.0257295173,1.418258117566993,0.5041201214670571,0.09150472724659171,0.4407379248873613,Upregulated
Feature0022,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0022,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,2573851.3692005435,2343379.6848989935,0.9104564905886015,-0.13533802036717782,0.48089217387924615,0.668084909379413,Downregulated
Feature0021,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0021,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,3377975.5921415435,4008280.2042277935,1.1865924116066968,0.24682446174132536,0.06952447986121839,0.4407144994592488,Upregulated
Feature0020,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0020,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,245131.70078720368,446482.77858198935,1.8213995870308772,0.8650474621212103,0.08273734637752764,0.4407379248873613,Upregulated
Feature0019,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,166500.01487883533,135764.77739545866,0.8154039955747561,-0.2944130686694831,0.06672531511602575,0.43620489220914954,Downregulated
Feature0018,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,214705.48481079066,235094.377073221,1.0949621397906908,0.1308809870131978,0.8325557503973996,0.908833353493674,Upregulated
Feature0017,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0017,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1375476.52122804,1494452.32571116,1.086497881023005,0.11968536086012227,0.06429266479451959,0.43620489220914954,Upregulated
Feature0016,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2929633.93572467,2951264.8665212635,1.007383492706314,0.010612995860714337,0.936433138658433,0.9698394378801211,Upregulated
Feature0015,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0015,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,4171012.0488922135,3883123.799265683,0.9309788017267917,-0.10317977671855853,0.40589050280087685,0.6115057027381818,Downregulated
Feature0014,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0014,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2855400.72516914,2648559.1653037467,0.9275612848164627,-0.10848548983328679,0.1368430256942942,0.470482482651178,Downregulated
Feature0013,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1477600.6286191668,1693295.5699963432,1.145976481871658,0.19657743690870616,0.5084405601901407,0.6871399222855217,Upregulated
Feature0012,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,402250.9382596853,149886.52732242498,0.372619459810088,-1.424225074825714,0.2132120307859366,0.49223024391321163,Downregulated
Feature0011,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,120425.06717976867,97587.0873660534,0.8103552661538226,-0.30337355929634396,0.027505401671251987,0.39036770986176245,Downregulated
Feature0010,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0010,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,351050.979208221,219478.63552466268,0.6252044532668344,-0.6776000403452161,0.10781106803355836,0.45172120667857957,Downregulated
Feature0009,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0009,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,331523.223902266,201221.146425824,0.6069594282334337,-0.7203280110961403,0.2418488461166355,0.5073945532162878,Downregulated
Feature0008,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,193072.87871715214,163492.421505848,0.8467912354762219,-0.2399217577577639,0.6657236923555414,0.7974150747314289,Downregulated
Feature0007,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0007,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,319918.49620326934,355544.4775051783,1.1113595547763295,0.15232564298484405,0.2227325301070105,0.49581507401192965,Upregulated
Feature0006,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,3610942.1630187435,3663115.4420387,1.0144486609490138,0.020695855268642694,0.883901171562328,0.9427158883012662,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,1263559.4235147967,1110361.419890365,0.8787567875531439,-0.18646416722401923,0.27771750575642856,0.5381676018285196,Downregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,2413671.3202840933,350339.27814107534,0.1451478812367211,-2.784404582182761,5.080575214108071e-4,0.10568987119826409,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,436403.444635801,458370.656296037,1.050336934619223,0.07085220020527726,0.5803013158059003,0.7373704148745415,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,79492.74799803837,68128.34241165197,0.8570384610849429,-0.22256814565875382,0.08074090502795948,0.4407379248873613,Downregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,1590000.5010162499,1249151.9150754074,0.7856298877119919,-0.34807827975400435,0.18596972482970967,0.48745712214463777,Downregulated
